EurekaMag PDF full texts Chapter 39,218

Appelboom, T.; Famaey, J.P. 1977: Allopurinol and gouty hyperuricemia : apropos of 30 cases treated by a single daily dose. Bruxelles Medical 57(3): 133-137

Rodnan, G.P.; Robin, J.A.; Tolchin, S.F.; Elion, G.B. 1975: Allopurinol and gouty hyperuricemia. Efficacy of a single daily dose. JAMA 231(11): 1143-1147

Godin, D.V.; Ko, K. 1991: Allopurinol and ischemia/reperfusion injury: new use for an old drug?. Canadian Journal of Cardiology 7(4): 163-169

Schirmer, W.J.; Schirmer, J.M.; Naff, G.B.; Fry, D.E. 1988: Allopurinol and lodoxamide in complement-induced hepatic ischemia. Journal of Surgical Research 45(1): 28-36

Moorhouse, P.C.; Grootveld, M.; Halliwell, B.; Quinlan, J.G.; Gutteridge, J.M. 1987: Allopurinol and oxypurinol are hydroxyl radical scavengers. Febs Letters 213(1): 23-28

Crome, R.; Manning, A.S. 1988: Allopurinol and reperfusion-induced arrhythmias: increased protection by simultaneous administration of anti-oxidant enzymes. Cardiovascular Drugs and Therapy 2(3): 295-304

Rosati, R.; Stortoni, F.; Filingeri, V.; Svegliati, F.; Cervelli, V.; Casciani, C.U. 1988: Allopurinol and superoxide dismutase administration in prevention of rat kidney ischemic injury. Transplantation Proceedings 20(5): 928-930

Kohri, K.; Kodama, M.; Katayama, Y.; Ishikawa, Y.; Takada, M.; Kataoka, K.; Katoh, Y.; Iguchi, M.; Kurita, T. 1990: Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones. Urology 36(4): 309-314

Paterson, P.J. 1978: Allopurinol and urinary stones. British Medical Journal 1(6104): 51

Sander, J.W.; Patsalos, P.N. 1988: Allopurinol as an add-on drug in the management of intractable epilepsy. Epilepsy Research 2(3): 223-225

Krasny, H.C.; Krenitsky, T.A. 1986: Allopurinol as an inhibitor of the in vivo formation of acyclovir from desciclovir. Biochemical Pharmacology 35(23): 4339-4340

Chan, H.L.; Ku, G.; Khoo, O.T. 1977: Allopurinol associated hypersensitivity reactions: cutaneous and renal manifestations. Australian and New Zealand Journal of Medicine 7(5): 518-522

Peterson, D.A.; Kelly, B.; Gerrard, J.M. 1986: Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury?. Biochemical and Biophysical Research Communications 137(1): 76-79

Ulmann, A. 1987: Allopurinol for the prevention of calcium oxalate calculi. New England Journal of Medicine 316(22): 1415-1416

Chawla, S.K.; Patel, H.D.; Parrino, G.R.; Soterakis, J.; Lopresti, P.A.; D'Angelo, W.A. 1977: Allopurinol hepatotoxicity. Case report and literature review. Arthritis and Rheumatism 20(8): 1546-1549

McKendrick, M.W.; Geddes, A.M. 1979: Allopurinol hypersensitivity. British Medical Journal 1(6169): 988

Simons, R.J. 1987: Allopurinol hypersensitivity can be fatal. Pennsylvania Medicine 90(12): 46; 48

McDonald, J.; Fam, A.G.; Paton, T.; Senn, J. 1988: Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout. Journal of Rheumatology 15(5): 865-868

Vanderstigel, M.; Zafrani, E.S.; Lejonc, J.L.; Schaeffer, A.; Portos, J.L. 1986: Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterology 90(1): 188-190

Stein, C.M. 1985: Allopurinol hypersensitivity. A case report. South African Medical Journal 67(23): 935-936

Utsinger, P.D.; Young, W.J. 1976: Allopurinol hypersensitivity. Granular deposition of IgM at the dermal-epidermal junction. American Journal of Medicine 61(2): 287-294

Thomson, W.H.; Smith, I. 1978: Allopurinol in Duchenne's muscular dystrophy. New England Journal of Medicine 299(2): 101

Kamilli, I.; Gresser, U.; Schaefer, C.; Zöllner, N. 1991: Allopurinol in breast milk. Advances in Experimental Medicine and Biology 309a: 143-145

Emerit, I.; Fabiani, J.N. 1990: Allopurinol in ischemia--reperfusion injury of heart. Advances in Experimental Medicine and Biology 264: 367-372

Simmonds, H.A.; Cameron, J.S.; Morris, G.S.; Davies, P.M. 1986: Allopurinol in renal failure and the tumour lysis syndrome. Clinica Chimica Acta; International Journal of Clinical Chemistry 160(2): 189-195

Guzeva, V.I.; Gusel', V.A.; Mikhaĭlov, I.B. 1988: Allopurinol in the combined therapy of severe forms of epilepsy in children. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(6): 69-72

Di Vita, G.; Frazzetta, M.; Asaro, M.; Asadollahpour, M. 1988: Allopurinol in the genesis of postoperative peritoneal adhesions. Il Giornale di Chirurgia 9(12): 853-856

Herwaldt, B.L.; Neva, F.A.; Berman, J.D. 1992: Allopurinol in the treatment of American cutaneous leishmaniasis. New England Journal of Medicine 327(7): 498-499

Rakhmatov, A.B. 1986: Allopurinol in the treatment of psoriasis patients. Vestnik Dermatologii i Venerologii 1: 58-59

Ohno, I.; Ishida, Y.; Hosoya, T.; Kobayashi, M.; Sakai, O. 1990: Allopurinol induced aplastic anemia in a patient with chronic renal failure. Ryumachi 30(4): 281-286

Kjaeve, J.; Veel, T.; Bjertnaes, L. 1990: Allopurinol inhibits hypoxic pulmonary vasoconstriction. Role of toxic oxygen metabolites. Acta Anaesthesiologica Scandinavica 34(5): 384-388

Green, C.J.; Healing, G.; Simpkin, S.; Gower, J.; Fuller, B.J. 1989: Allopurinol inhibits lipid peroxidation in warm ischaemic and reperfused rabbit kidneys. Free Radical Research Communications 6(5): 329-337

Ferner, R.E.; Simmonds, H.A.; Bateman, D.N. 1988: Allopurinol kinetics after massive overdosage. Human Toxicology 7(3): 293-294

Loprinzi, C.L.; Burnham, N. 1989: Allopurinol mouthwash as prophylactic therapy for 5-fluorouracil-induced mucositis. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 15(3): 297

Van der Vliet, W.; Erlichman, C.; Elhakim, T. 1989: Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis. Clinical Pharmacy 8(9): 655-658

Clark, P.I.; Slevin, M.L. 1985: Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 11(3): 267-268

Bakouche, P.; Chaouat, D.; Nick, J. 1979: Allopurinol not effective in muscular dystrophy. New England Journal of Medicine 301(14): 785

Williams, G.D.; Palmer, C.; Heitjan, D.F.; Smith, M.B. 1992: Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: a 31P NMR study in unanesthetized immature rats. Neuroscience Letters 144(1-2): 103-106

Vaughan, W.G.; Horton, J.W.; Walker, P.B. 1992: Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. Journal of Pediatric Surgery 27(8): 968

Ansari, N.H.; Srivastava, S.K. 1990: Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis. Biochemical and Biophysical Research Communications 168(3): 939-943

Nelson, D.J.; LaFon, S.W.; Tuttle, J.V.; Miller, W.H.; Miller, R.L.; Krenitsky, T.A.; Elion, G.B.; Berens, R.L.; Marr, J.J. 1979: Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation. Journal of Biological Chemistry 254(22): 11544-11549

Haughey, D.B.; Lanse, S.; Imhoff, T.; Tobin, M.; Schentag, J.J. 1979: Allopurinol sensitivity: report of two cases. American Journal of Hospital Pharmacy 36(10): 1377-1380

Zöllner, N. 1977: Allopurinol side effect?. Deutsche Medizinische Wochenschrift 102(38): 1363

Wolfram, G. 1978: Allopurinol therapy of nephrolithiasis. Deutsche Medizinische Wochenschrift 103(4): 147

Sergent, J.S. 1979: Allopurinol toxicity. Southern Medical Journal 72(11): 1359-1360

Calin, A. 1978: Allopurinol toxicity masquerading as malignancy. JAMA 239(6): 497

Guérin, C.; Genin, C.; Toulon, J.; Sabatier, J.C.; Leroy, G.; Berthoux, F. 1986: Allopurinol toxicity. Apropos of 1 case. Nephrologie 7(2): 47-49

Morris, J.N.; Marr, J.W.; Clayton, D.G. 1977: Diet and heart: a postscript. British Medical Journal 2(6098): 1307-1314

Oredsson, S.; Plate, G.; Qvarfordt, P. 1991: Allopurinol--a free radical scavenger--reduces reperfusion injury in skeletal muscle. European Journal of Vascular Surgery 5(1): 47-52

Reiter, S.; Löffler, W.; Gröbner, W.; Zöllner, N. 1986: Allopurinol-1-riboside formation and HGPRT-deficiency. Advances in Experimental Medicine and Biology 195 Pt A: 447-451

Gottlieb, N.L.; Gray, R.G. 1977: Allopurinol-associated hand and foot deformities in chronic tophaceous gout. JAMA 238(15): 1663-1664

Boyd, I.W. 1991: Allopurinol-azathioprine interaction. Journal of Internal Medicine 229(4): 386

Mertz, D.P.; Göhmann, E. 1978: Allopurinol-benzbromarone combination. Renal excretion of various ions during high-dosage therapy using an allopurinol-benzbromarone combination. ZFA. Zeitschrift für Allgemeinmedizin 54(14): 811-815

Fellner, M.J. 1976: Allopurinol-caused toxic epiderman necrolysis. Archives of Dermatology 112(9): 1327

Chambers, D.J.; Takahashi, A.; Humphrey, S.M.; Harvey, D.M.; Hearse, D.J. 1992: Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage. Basic Research in Cardiology 87(3): 227-238

Boyer, T.D.; Sun, N.; Reynolds, T.B. 1977: Allopurinol-hypersensitivity vasculitis and liver damage. Western Journal of Medicine 126(2): 143-147

Weiss, E.B.; Forman, P.; Rosenthal, I.M. 1978: Allopurinol-induced arteritis in partial HGPRTase deficiency. Atypical seizure manifestation. Archives of Internal Medicine 138(11): 1743-1744

Jenkinson, S.G.; Roberts, R.J.; DeLemos, R.A.; Lawrence, R.A.; Coalson, J.J.; King, R.J.; Null, D.M.; Gerstmann, D.R. 1991: Allopurinol-induced effects in premature baboons with respiratory distress syndrome. Journal of Applied Physiology 70(3): 1160-1167

Swank, L.A.; Chejfec, G.; Nemchausky, B.A. 1978: Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Archives of Internal Medicine 138(6): 997-998

Gelbart, D.R.; Weinstein, A.B.; Fajardo, L.F. 1977: Allopurinol-induced interstitial nephritis. Annals of Internal Medicine 86(2): 196-198

Pewsner, D.; Bachmann, C.; Müller, U. 1987: Allopurinol-induced kidney failure with hepatitis and squamous dermatitis in pre-existing kidney insufficiency. Schweizerische Medizinische Wochenschrift 117(4): 139-141

Goodstein, D.B.; Himmelfarb, R. 1975: Allopurinol-induced mandibular neuropathy. Abbreviated case report. Oral Surgery Oral Medicine and Oral Pathology 40(1): 51-52

Frost, S.K.; Bagnara, J.T. 1979: Allopurinol-induced melanism in the tiger salamander (Ambystoma tigrinum nebulosum). Journal of Experimental Zoology 209(3): 455-466

Wexler, B.C.; Greenberg, B.P. 1978: Allopurinol-induced myocardial and renal damage in nonarteriosclerotic (virgin) and arteriosclerotic (breeder) Sprague-Dawley rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 157(4): 541-549

Ansari, N.H.; Rajaraman, S. 1992: Allopurinol-induced nephrotoxicity: protection by the antioxidant, butylated hydroxytoluene. Research Communications in Chemical Pathology and Pharmacology 75(2): 221-229

Tuchman, M. 1990: Allopurinol-induced orotidinuria. New England Journal of Medicine 323(19): 1352-1353

Hauser, E.R.; Finkelstein, J.E.; Valle, D.; Brusilow, S.W. 1990: Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. New England Journal of Medicine 322(23): 1641-1645

Nakamura, M. 1991: Allopurinol-insensitive oxygen radical formation by milk xanthine oxidase systems. Journal of Biochemistry 110(3): 450-456

Howard, R.J.; Blake, D.R.; Pall, H.; Williams, A.; Green, I.D. 1987: Allopurinol/N-acetylcysteine for carbon monoxide poisoning. Lancet 2(8559): 628-629

Ulrich, R.G.; Atassi, M.Z. 1989: Alloreactive T cell recognition of the HLA-DR beta N-terminal polymorphic region. Immunology Letters 21(4): 285-290

Irle, C.; Beatty, P.G.; Mickelson, E.; Thomas, E.D.; Hansen, J.A. 1985: Alloreactive T cell responses between HLA-identical siblings. Detection of anti-minor histocompatibility T cell clones induced in vivo. Transplantation 40(3): 329-333

Simonsen, M. 1990: Alloreactive T cells. Scandinavian Journal of Immunology 32(6): 565-575

Mickelson, E.M.; Masewicz, S.A.; Nepom, G.T.; Martin, P.J.; Hansen, J.A. 1991: Alloreactive T-cell clones identify multiple HLA-DQw3 variants. Human Immunology 30(1): 32-40

Eiermann, T.H.; Winkelmann, S.; Ballas, M.; Wölpl, A.; Goldmann, S.F. 1990: Alloreactive T-cell clones raised in an HLA-B/D crossing-over family dissect HLA-DR5 and HLA-DQw3 subtypes. Human Immunology 29(2): 117-130

Glass, E.J.; Oliver, R.A.; Williams, J.L.; Millar, P. 1992: Alloreactive T-cell recognition of bovine major histocompatibility complex class Ii products defined by one-dimensional isoelectric focusing. Animal Genetics 23(2): 97-111

Zeevi, A.; Cascino, I.; Di Vecchia, L.; Marrari, M.; Duquesnoy, R.J.; Trucco, M. 1987: Alloreactive T-cell recognition of two DQ beta allelic specificities associated with DQw1. Human Immunology 18(3): 225-234

Pawelec, G.; Wernet, P. 1987: Alloreactive T-lymphocyte clones detecting epitopes uniquely expressed on HLA-D homozygous cells. Human Immunology 19(4): 279-286

Aparicio, P.; Jaraquemada, D.; López de Castro, J.A. 1987: Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity. Journal of Experimental Medicine 165(2): 428-443

Arnold, B.; Horstmann, U.; Kuon, W.; Burgert, H.G.; Hämmerling, G.J.; Kvist, S. 1985: Alloreactive cytolytic T-cell clones preferentially recognize conformational determinants on histocompatibility antigens: analysis with genetically engineered hybrid antigens. Proceedings of the National Academy of Sciences of the United States of America 82(20): 7030-7034

Reimann, J.; Heeg, K.; Miller, R.G.; Wagner, H. 1985: Alloreactive cytotoxic T cells. I. Alloreactive and allorestricted cytotoxic T cells. European Journal of Immunology 15(4): 387-393

Kaminski, E.; Hows, J.; Brookes, P.; Mackinnon, S.; Hughes, T.; Avakian, O.; Sharrock, C.; Goldman, J.; Batchelor, J.R. 1989: Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors. Transplantation Proceedings 21(1 Part 3): 2976-2977

Rimm, I.J.; Ghayur, T.; Gasser, D.L.; Rosenkrantz, K.; Burakoff, S.J.; Seidman, J.G.; Ferrara, J.L. 1991: Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction. Journal of Immunology 146(4): 1130-1133

Lazić, M. 1985: Alloreactive lymphocytotoxic antibodies in patients with multiple transfusions and on a chronic hemodialysis program. Srpski Arhiv Za Celokupno Lekarstvo 113(11-12): 973-981

Ouwehand, A.J.; Vaessen, L.M.; Baan, C.C.; Jutte, N.H.; Balk, A.H.; Essed, C.E.; Bos, E.; Claas, F.H.; Weimar, W. 1991: Alloreactive lymphoid infiltrates in human heart transplants. Loss of class II-directed cytotoxicity more than 3 months after transplantation. Human Immunology 30(1): 50-59

Dissen, E.; Vaage, J.T.; Taskén, K.; Jahnsen, T.; Rolstad, B.; Fossum, S. 1990: Alloreactive lymphokine-activated killer cells from athymic nude rats do not express CD3-associated alpha/beta or gamma/delta T cell receptors. International Immunology 2(5): 453-460

Hutchinson, I.V.; Morris, P.J. 1987: Alloreactive suppressor T cells. Transplantation Proceedings 19(1 Part 1): 528-530

Yoshimura, N.; Matsui, S.; Hamashima, T.; Oka, T. 1988: Alloreactive suppressor T cells and cytokine (gamma-IFN, interleukin 1, 2, and 3) production in cyclosporine-treated mice. Transplantation Proceedings 20(3 Suppl 3: 1016-1024

Fujimoto, H. 1989: Alloreactivity and mitogen-induced responses in allogeneic murine bone marrow chimeras. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(5): 858-868

Friedman, S.; Sillcocks, D.; Cantor, H. 1987: Alloreactivity of an OVA-specific T-cell clone. I. Stimulation by class Ii MHC and novel non-MHC B-cell determinants. Immunogenetics 26(4-5): 193-203

Santos-Aguado, J.; Crimmins, M.A.; Mentzer, S.J.; Burakoff, S.J.; Strominger, J.L. 1989: Alloreactivity studied with mutants of HLA-A2. Proceedings of the National Academy of Sciences of the United States of America 86(22): 8936-8940

Barrett, L.V.; Rimm, I.J.; Wiens, G.R.; Seidman, J.G.; Kirkman, R.L. 1991: Allorecognition in T-cell receptor (beta-chain) transgenic mice. Surgery 110(2): 385-388; Discussion: 388-389

Lambot, M.; Hubert, P.; Letesson, J.J.; Depelchin, A. 1992: Allorecognition of BoLA class Ii molecules presented in vitro in liposome membranes. Annales de Recherches Veterinaires. Annals of Veterinary Research 23(3): 293-294

Wilson, K.E.; Ball, E.; Stasny, P.; Capra, J.D. 1991: Allorecognition of HLA DR2 and DR5 molecules by V-beta-8-positive T-cell clones. Scandinavian Journal of Immunology 33(2): 131-139

Hiraiwa, M.; Takiguchi, M.; Kano, K. 1991: Allorecognition of HLA-B5 cross reactive group antigens by human CTL clones. Transplantation Proceedings 23(1 Part 1): 449-450

Gjersten, H.A.; Lundin, K.E.; Kwok, W.W.; Nepom, G.T.; Thorsby, E. 1992: Allorecognition of HLA-DQw8 molecules: influence of single amino acid substitutions. Tissue Antigens 39(2): 95-98

Merkenschlager, M.; Ikeda, H.; Wilkinson, D.; Beverly, P.C.; Trowsdale, J.; Fisher, A.G.; Altmann, D.M. 1991: Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements. European Journal of Immunology 21(1): 79-88

Elliott, T.J.; Eisen, H.N. 1988: Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 85(8): 2728-2732

Ildstad, S.T.; Bluestone, J.A.; Sachs, D.H. 1986: Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn). Journal of Experimental Medicine 163(5): 1343-1348

Reimann, J.; Kabelitz, D.; Heeg, K.; Wagner, H. 1985: Allorestricted cytotoxic T cells. Large numbers of allo-H-2Kb-restricted antihapten and antiviral cytotoxic T cell populations clonally develop in vitro from murine splenic precursor T cells. Journal of Experimental Medicine 162(2): 592-606

Hilton, A.; Nikolic, G. 1988: Allorhythmic complex of complex complexes. Heart and Lung: the Journal of Critical Care 17(3): 317-318

Satullo, G.; Oreto, G.; Luzza, F.; Paleologo, G.; Schamroth, L. 1988: Allorhythmic preexcitation due to anterograde concealed Kent bundle conduction. American Journal of Cardiology 61(8): 652-654

Sesterhenn, K.; Dostal, G.; Mohr, R.; Hilfrich, J.; Hermann, G. 1977: Allorosettes after renal transplantation in inbred strains of rats. Research in Experimental Medicine. Zeitschrift für die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie 169(1): 71-82

Leshem, B.; Epstein, E.; Kedar, E. 1989: Allosensitization in IL-2-containing limiting dilution cultures generates cytotoxic T lymphocytes (CTL) rather than LAK cells reactive with a syngeneic nonimmunogenic murine tumor. Immunology Letters 20(1): 53-58

Thakur, V.S.; Seshadri, M.; Poduval, T.B.; Shah, D.H.; Sundaram, K. 1990: Allosensitization induced suppression of various murine tumors: role of non-H-2 antigens in antitumor immunity. Indian Journal of Experimental Biology 28(8): 706-710

Jordan, M.L.; Carlson, A.; Hoffman, R.A.; Simmons, R.L. 1988: Allosensitized helper and cytotoxic T-lymphocyte clones differentially modulate endotoxin-stimulated macrophage function. Archives of Surgery 123(2): 182-187

Dower, S.M.; Piccinini, L.A.; Roman, S.H.; Safirstein, R.; Davies, T.F. 1988: Allospecific DR gene expression on the human thyroid cell. Autoimmunity 1(1): 37-44

Wallace, L.E.; Houghton, M.A.; Rickinson, A.B.; Epstein, M.A.; Bradley, B.A. 1985: Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes. Immunogenetics 21(3): 201-214

Song, E.S.; Linsk, R.; Olson, C.A.; McMillan, M.; Goodenow, R.S. 1988: Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class i molecule. Proceedings of the National Academy of Sciences of the United States of America 85(6): 1927-1931

Chen, L.K.; Bensussan, A.; Burns, G.F.; Tourvieille, B.; Soulié, A.; Sasportes, M. 1986: Allospecific proliferative human T-cell clones acquire the cytotoxic effector function after three months in culture, in IL-2 conditioned medium. Human Immunology 17(1): 30-36

Manca, F.; Halttunen, J.; Ferry, N.; Jakkola, M.; Gessaga, C.M.; Hayry, P. 1987: Allospecific rat-mouse T hybridoma clones generated from kidney graft-infiltrating cells. Transplantation 44(3): 440-442

Hayashi, H.; Ooba, T.; Nakayama, S.; Sekimata, M.; Kano, K.; Takiguchi, M. 1990: Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes. Immunogenetics 32(3): 195-199

Markus, B.H.; Demetris, A.J.; Fung, J.J.; Saidman, S.; Zeevi, A.; Starzl, T.E.; Duquesnoy, R.J. 1988: Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. Transplantation Proceedings 20(2): 219-222

Olsen, R.W.; Sapp, D.M.; Bureau, M.H.; Turner, D.M.; Kokka, N. 1991: Allosteric actions of central nervous system depressants including anesthetics on subtypes of the inhibitory gamma-aminobutyric acidA receptor-chloride channel complex. Annals of the new York Academy of Sciences 625: 145-154

Jensen, J.R.; Lynch, G.; Baudry, M. 1989: Allosteric activation of brain mitochondrial Ca2+ uptake by spermine and by Ca2+: brain regional differences. Journal of Neurochemistry 53(4): 1182-1187

Jensen, J.R.; Lynch, G.; Baudry, M. 1989: Allosteric activation of brain mitochondrial Ca2+ uptake by spermine and by Ca2+: developmental changes. Journal of Neurochemistry 53(4): 1173-1181

Ferrer, A.; Caelles, C.; Massot, N.; Hegardt, F.G. 1987: Allosteric activation of rat liver microsomal [hydroxymethylglutaryl-CoA reductase (NADPH)]kinase by nucleoside phosphates. Biological Chemistry Hoppe-Seyler 368(3): 249-257

Erlanger, B.F.; Wassermann, N.H.; Cooper, A.G.; Monk, R.J. 1976: Allosteric activation of the hydrolysis of specific substrates by chymotrypsin. European Journal of Biochemistry 61(1): 287-295

Robinson, J.P.; Fraenkel, D.G. 1978: Allosteric and non-allosteric E. coli phosphofructokinases: effects on growth. Biochemical and Biophysical Research Communications 81(3): 858-863

Roitelman, J.; Shechter, I. 1986: Allosteric and non-allosteric forms of rat liver 3-hydroxy-3-methylglutaryl coenzyme a reductase: differential inhibition of activity by adenosine 2'-monophospho-5'-diphosphoribose. Journal of Lipid Research 27(8): 828-835

Childs, R.E.; Bardsley, W.G. 1975: Allosteric and related phenomena: an analysis of sigmoid and non-hyperbolic functions. Journal of Theoretical Biology 50(1): 45-58

Lee, N.H.; el-Fakahany, E.E. 1991: Allosteric antagonists of the muscarinic acetylcholine receptor. Biochemical Pharmacology 42(2): 199-205

Tabushi, I.; Kugimiya, S. 1988: Allosteric behavior of artificial compounds. Biomaterials Artificial Cells and Artificial Organs 16(1-3): 321-329

Raos, N.; Kasprzak, K.S. 1989: Allosteric binding of nickel(II) to calmodulin. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 13(4): 816-822

Gregoriou, M.; Trayer, I.P.; Cornish-Bowden, A. 1986: Allosteric character of the inhibition of rat-muscle hexokinase B by glucose 6-phosphate. European Journal of Biochemistry 161(1): 171-176

Brouwer, M.; Serigstad, B. 1989: Allosteric control in Limulus polyphemus hemocyanin: functional relevance of interactions between hexamers. Biochemistry 28(22): 8819-8827

Abuelgassim, A.O.; Salem, A.M.; Khoja, S.M. 1992: Allosteric control of 6-phosphofructo-1-kinase from rat lung. Comparative Biochemistry and Physiology. B Comparative Biochemistry 101(1-2): 135-138

Stevens, R.C.; Lipscomb, W.N. 1990: Allosteric control of quaternary states in E. coli aspartate transcarbamylase. Biochemical and Biophysical Research Communications 171(3): 1312-1318

Vogt, B.; Vakalopoulou, E.; Fanning, E. 1986: Allosteric control of simian virus 40 T-antigen binding to viral origin DNA. Journal of Virology 58(3): 765-772

Chaires, J.B. 1986: Allosteric conversion of Z DNA to an intercalated right-handed conformation by daunomycin. Journal of Biological Chemistry 261(19): 8899-8907

Blatt, Y.; Pecht, I. 1979: Allosteric cooperative interactions among redox sites of Pseudomonas cytochrome oxidase. Biochemistry 18(13): 2917-2922

Ahearn, G.A.; Tornquist, A. 1977: Allosteric cooperativity during intestinal cotransport of sodium and chloride in freshwater prawns. Biochimica et Biophysica Acta 471(2): 273-279

Machida, M.; Yokoyama, S.; Matsuzawa, H.; Miyazawa, T.; Ohta, T. 1985: Allosteric effect of fructose 1,6-bisphosphate on the conformation of NAD+ as bound to L-lactate dehydrogenase from Thermus caldophilus GK24. Journal of Biological Chemistry 260(30): 16143-16147

Taketa, F.; Chen, J.Y.; Skogen, W.F.; Litwin, S.B.; Laver, M.B. 1978: Allosteric effect of o-iodobenzoate on hemoglobin. Hemoglobin 2(3): 261-273

Lopina, O.D.; Boldyrev, A.A. 1977: Allosteric effect of substrate on sarcoplasmic reticulum Ca-ATPase. Biokhimiia 42(3): 436-442

Minami, M.; Takahashi, T.; Maruyama, W.; Takahashi, A.; Nagatsu, T.; Naoi, M. 1992: Allosteric effect of tetrahydrobiopterin cofactors on tyrosine hydroxylase activity. Life Sciences 50(1): 15-20

Houben, K.F.; Dunn, M.F. 1990: Allosteric effects acting over a distance of 20-25 a in the Escherichia coli tryptophan synthase bienzyme complex increase ligand affinity and cause redistribution of covalent intermediates. Biochemistry 29(9): 2421-2429

Wong, I.; Lohman, T.M. 1992: Allosteric effects of nucleotide cofactors on Escherichia coli Rep helicase-DNA binding. Science 256(5055): 350-355

Christensen, U. 1978: Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin. Biochimica et Biophysica Acta 526(1): 194-201

Louie, G.; Tran, T.; Englander, J.J.; Englander, S.W. 1988: Allosteric energy at the hemoglobin beta chain C terminus studied by hydrogen exchange. Journal of Molecular Biology 201(4): 755-764

Bruns, R.F.; Fergus, J.H. 1990: Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. Molecular Pharmacology 38(6): 939-949

Dénes, G.; Nagy, J. 1976: Allosteric enzyme-tRNA complexes as regulators of transcription or translation. Acta Microbiologica Academiae Scientiarum Hungaricae 23(2): 171-180

Saiki, T. 1975: Allosteric enzymes of thermophilic bacteria. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 20(3): 188-193

Andrés, V.; García-Salguero, L.; Gómez, M.E.; Aragón, J.J. 1988: Allosteric inhibition of Dictyostelium discoideum fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate. Febs Letters 241(1-2): 51-54

Ureta, T.; Lazo, P.A.; Sols, A. 1985: Allosteric inhibition of brain hexokinase by glucose 6-phosphate in the reverse reaction. Archives of Biochemistry and Biophysics 239(2): 315-319

Skridonenko, A.D. 1975: Allosteric inhibition of nuclear endoribonuclease activity by a natural inhibitor. Doklady Akademii Nauk SSSR 221(1): 232-234

Dallocchio, F.; Bellini, T.; Martuscelli, G.; Baiocchi, M.; Tomasi, M. 1991: Allosteric inhibition of the water-soluble C-terminal fragment of Sendai virus neuraminidase. Biochemistry International 25(4): 663-668

Meyerson, L.R.; Ieni, J.R.; Wennogle, L.P. 1987: Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets. Journal of Neurochemistry 48(2): 560-565

Plucinski, T.M.; Fager, R.S.; Reddy, G.P. 1990: Allosteric interaction of components of the replitase complex is responsible for enzyme cross-inhibition. Molecular Pharmacology 38(1): 114-120

Knaus, G.A.; Knaus, H.G.; Saria, A. 1991: Allosteric interaction of heparin with NK-1 receptors in rat striatal membranes. Annals of the new York Academy of Sciences 632: 422-425

Maelicke, A. 1987: Allosteric interactions between distinct structural domains at the nicotinic acetylcholine receptor. Biochemical Society Transactions 15(1): 108-112

Bulger, J.E.; Fu, J.L.; Hindy, E.F.; Silberstein, R.L.; Hess, G.P. 1977: Allosteric interactions between the membrane-bound acetylcholine receptor and chemical mediators. Kinetic studies. Biochemistry 16(4): 684-692

Fu, J.L.; Donner, D.B.; Moore, D.E.; Hess, G.P. 1977: Allosteric interactions between the membrane-bound acetylcholine receptor and chemical mediators: equilibrium measurements. Biochemistry 16(4): 678-684

Rheinberger, H.J.; Nierhaus, K.H. 1986: Allosteric interactions between the ribosomal transfer RNA-binding sites a and e. Journal of Biological Chemistry 261(20): 9133-9139

Bonaventura, J.; Bonaventura, C.; Amiconi, G.; Tentori, L.; Brunori, M.; Antonini, E. 1975: Allosteric interactions in non-alpha chains isolated from normal human hemoglobin, fetal hemoglobin, and hemoglobin Abruzzo (beta143 (H21) his replaced by Arg). Journal of Biological Chemistry 250(16): 6278-6281

Hess, G.P.; Bulger, J.E.; Fu, J.J.; Hindy, E.F.; Silberstein, R.J. 1975: Allosteric interactions of the membrane-bound acetylcholine reception: kinetic studies with alpha-bungarotoxin. Biochemical and Biophysical Research Communications 64(3): 1018-1027

Roffel, A.F.; Elzinga, C.R.; Meurs, H.; Zaagsma, J. 1989: Allosteric interactions of three muscarine antagonists at bovine tracheal smooth muscle and cardiac M2 receptors. European Journal of Pharmacology 172(1): 61-70

Bina-Stein, M.; Stein, A. 1976: Allosteric interpretation of Mg2+ binding to the denaturable Escherichia coli tRNAGlu2+. Biochemistry 15(18): 3912-3917

Di Cera, E.; Robert, C.H.; Gill, S.J. 1987: Allosteric interpretation of the oxygen-binding reaction of human hemoglobin tetramers. Biochemistry 26(13): 4003-4008

Huang, H.W. 1976: Allosteric linkage and phase transition. Physiological Chemistry and Physics 8(2): 143-150

Schweitzer-Stenner, R. 1989: Allosteric linkage-induced distortions of the prosthetic group in haem proteins as derived by the theoretical interpretation of the depolarization ratio in resonance Raman scattering. Quarterly Reviews of Biophysics 22(4): 381-479

Goad, W.B. 1977: Allosteric mechanics. Advances in Pathobiology 1977(6): 169-180

Matsukawa, S.; Mawatari, K.; Shimokawa, Y.; Takeda, Y.; Yoneyama, Y.; Itoh, M.; Kurokawa, H.; Kitagawa, T. 1985: Allosteric mechanism deduced from the analysis of the variation of structure and function of abnormal hemoglobins. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(8): 2002-2014

Kurland, C.G.; Rigler, R.; Ehrenberg, M.; Blomberg, C. 1975: Allosteric mechanism for codon-dependent tRNA selection on ribosomes. Proceedings of the National Academy of Sciences of the United States of America 72(11): 4248-4251

Siegel, H.N.; Lukas, R.J. 1986: Allosteric modification of alpha-bungarotoxin binding by the 'calcium channel antagonist' verapamil. Brain Research 387(1): 37-42

Nucci, R.; Raia, C.A.; Vaccaro, C.; Rossi, M.; Whitehead, E.P. 1991: Allosteric modifier and substrate binding of donkey deoxycytidylate aminohydrolase (EC 3.5.4.12). Archives of Biochemistry and Biophysics 289(1): 19-25

Randad, R.S.; Mahran, M.A.; Mehanna, A.S.; Abraham, D.J. 1991: Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. Journal of Medicinal Chemistry 34(2): 752-757

Wireko, F.C.; Kellogg, G.E.; Abraham, D.J. 1991: Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. Journal of Medicinal Chemistry 34(2): 758-767

Abraham, D.J.; Wireko, F.C.; Randad, R.S.; Poyart, C.; Kister, J.; Bohn, B.; Liard, J.F.; Kunert, M.P. 1992: Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31(38): 9141-9149

Larose, L.; McNicoll, N.; Ong, H.; De Léan, A. 1991: Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions. Biochemistry 30(37): 8990-8995

Sigel, E.; Baur, R. 1988: Allosteric modulation by benzodiazepine receptor ligands of the GABAA receptor channel expressed in Xenopus oocytes. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 8(1): 289-295

Reynolds, I.J.; Miller, R.J. 1990: Allosteric modulation of N-methyl-D-aspartate receptors. Advances in Pharmacology 21: 101-126

Nokin, P.; Clinet, M.; Swillens, S.; Delisée, C.; Meysmans, L.; Chatelain, P. 1986: Allosteric modulation of [3H]nitrendipine binding to cardiac and cerebral cortex membranes by amiodarone. Journal of Cardiovascular Pharmacology 8(5): 1051-1057

Musacchio, J.M.; Klein, M.; Santiago, L.J. 1987: Allosteric modulation of dextromethorphan binding sites. Neuropharmacology 26(7b): 997-1001

Chiu, T.H.; Rosenberg, H.C. 1985: Allosteric modulation of flunitrazepam binding to rat brain benzodiazepine receptors by methyl beta-carboline-3-carboxylate. Journal of Neurochemistry 44(1): 306-309

Sharkey, R.G.; Jover, E.; Couraud, F.; Baden, D.G.; Catterall, W.A. 1987: Allosteric modulation of neurotoxin binding to voltage-sensitive sodium channels by Ptychodiscus brevis toxin 2. Molecular Pharmacology 31(3): 273-278

Niles, L.P.; Peace, C.H. 1990: Allosteric modulation of t-[35S]butylbicyclophosphorothionate binding in rat brain by melatonin. Brain Research Bulletin 24(4): 635-638

Venieratos, D.; Goldbeter, A. 1979: Allosteric oscillatory enzymes: influence of the number of protomers on metabolic periodicities. Biochimie 61(11-12): 1247-1256

Decker, H.; Savel-Niemann, A.; Körschenhausen, D.; Eckerskorn, E.; Markl, J. 1989: Allosteric oxygen-binding properties of reassembled tarantula (Eurypelma californicum) hemocyanin with incorporated apo- or met-subunits. Biological Chemistry Hoppe-Seyler 370(6): 511-523

Lemoine, H.; Kaumann, A.J. 1986: Allosteric properties of 5-HT2 receptors in tracheal smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 333(2): 91-97

Baudin, V.; Pagnier, J.; Lacaze, N.; Bihoreau, M.T.; Kister, J.; Marden, M.; Kiger, L.; Poyart, C. 1992: Allosteric properties of haemoglobin beta 41 (C7) Phe-->Tyr: a stable, low-oxygen-affinity variant synthesized in Escherichia coli. Biochimica et Biophysica Acta 1159(2): 223-226

Chetverikova, E.P.; Rozanova, N.A. 1977: Allosteric properties of muscle creatine kinase. Biokhimiia 42(3): 481-489

Kawakita, N.; Yamazaki, M. 1978: Allosteric properties of nucleoside diphosphatase. Activation by pyridoxal 5'-phosphate and specific modification of effector binding sites. Biochemistry 17(17): 3546-3551

Frenken, M.; Kaumann, A.J. 1987: Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators. Naunyn-Schmiedeberg's Archives of Pharmacology 335(4): 359-366

Kimura, A.; Takewaki, S.; Matsui, H.; Kubota, M.; Chiba, S. 1990: Allosteric properties, substrate specificity, and subsite affinities of honeybee alpha-glucosidase i. Journal of Biochemistry 107(5): 762-768

Komissarov, I.V. 1990: Allosteric receptor modulators--a new model for designing drugs. Farmakologiia i Toksikologiia 53(5): 3-7

Hanc, O. 1975: Allosteric regulation and models of receptors. Ceskoslovenska Farmacie 24(10): 437-440

Bobruskin, I.D.; Shaĭkhin, S.M.; Muratova, M.V.; Baranova, L.A.; Severin, E.S. 1987: Allosteric regulation of Ca2+-calmodulin-dependent phosphodiesterase activity from the bovine brain. Biokhimiia 52(8): 1344-1352

Howlett, G.J.; Blackburn, M.N.; Compton, J.G.; Schachman, H.K. 1977: Allosteric regulation of aspartate transcarbamoylase. Analysis of the structural and functional behavior in terms of a two-state model. Biochemistry 16(23): 5091-5100

Bedino, S. 1977: Allosteric regulation of beef liver arginase activity by L-ornithine. Italian Journal of Biochemistry 26(4): 264-276

Eriksson, S.; Thelander, L. 1978: Allosteric regulation of calf thymus ribonucleotide reductase. Ciba Foundation Symposium 68: 165-175

Cable, M.B.; Briggs, F.N. 1988: Allosteric regulation of cardiac sarcoplasmic reticulum Ca-ATPase: a comparative study. Molecular and Cellular Biochemistry 82(1-2): 29-36

Tinteris, L.V.; Shaposhnikov, A.M. 1978: Allosteric regulation of ceruloplasmin activity. Biokhimiia 43(6): 979-987

Ellis, J.; Huyler, J.; Brann, M.R. 1991: Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochemical Pharmacology 42(10): 1927-1932

Chiba, H. 1977: Allosteric regulation of enzymes in carbohydrate metabolism. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 22(12): 1737-1738

Novotny, M.J.; Frederickson, W.L.; Waygood, E.B.; Saier, M.H. 1985: Allosteric regulation of glycerol kinase by enzyme IIIglc of the phosphotransferase system in Escherichia coli and Salmonella typhimurium. Journal of Bacteriology 162(2): 810-816

Dumora, C.; Lacoste, A.M.; Cassaigne, A.; Mazat, J.P. 1991: Allosteric regulation of phosphonoacetaldehyde hydrolase by n-butylphosphonic acid. Biochemical Journal 280: 557-559

Geppert, A.G.; Binder, B.R. 1992: Allosteric regulation of tPA-mediated plasminogen activation by a modifier mechanism: evidence for a binding site for plasminogen on the tPA A-chain. Archives of Biochemistry and Biophysics 297(2): 205-212

Fetisova, L.V. 1987: Allosteric regulation of the oxygen affinity of human and bovine hemoglobins and hemoglobin polymers. Gematologiia i Transfuziologiia 32(10): 34-37

Wang, X.; Song, H.Y. 1989: Allosteric regulation of the state of adenylylation of glutamine synthetase in permeabilized cell preparations of Rhodopseudomonas sphaeroides. Science in China. Series B Chemistry Life Sciences and Earth Sciences 32(8): 960-969

Laurent, M.; Seydoux, F.J.; Dessen, P. 1979: Allosteric regulation of yeast phosphofructokinase. Correlation between equilibrium binding, spectroscopic and kinetic data. Journal of Biological Chemistry 254(16): 7515-7520

Chuvilin, A.N.; Serebrennikova, G.A.; Evstigneeva, R.P. 1990: Allosteric regulators of reversible oxygenation of hemoglobin. Bioorganicheskaia Khimiia 16(9): 1157-1176

Ray, J.; Englander, S.W. 1986: Allosteric sensitivity in hemoglobin at the alpha-subunit N-terminus studied by hydrogen exchange. Biochemistry 25(10): 3000-3007

Repke, K.R. 1988: Allosteric short-term regulation of ATP synthase: a plausible model. Progress in Clinical and Biological Research 273: 401-407

Jepsen, K.; Lüllmann, H.; Mohr, K.; Pfeffer, J. 1988: Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication. Pharmacology and Toxicology 63(3): 163-168

Weber, R.E.; Kleinschmidt, T.; Abbassi, A.; Wells, R.M.; Braunitzer, G. 1989: Allosteric transition in hemoglobin (alpha 2A beta 2I) from the rhynchocephalian reptile relict Sphenodon punctatus. Hemoglobin 13(7-8): 625-636

Jullien, M.; Baudet, S.; Rodier, F.; Le Bras, G. 1988: Allosteric transition of aspartokinase I-homoserine dehydrogenase i studied by time-resolved fluorescence. Biochimie 70(12): 1807-1814

Goldemberg, A.L.; García, A.M.; Fernández, H.; Fortunato, M.; Sánchez, J.J.; Trucco, R.E. 1988: Allosteric transition of erythrocyte alkaline phosphatase from Duchenne muscular dystrophy (DMD) patients and Duchenne muscular dystrophy carriers (Homo sapiens). International Journal of Biochemistry 20(7): 703-706

Chien, J.C.; Snyder, F.W. 1976: Allosteric transitions in cobalt hemoglobins. Journal of Biological Chemistry 251(6): 1670-1674

Komissarov, I.V. 1985: Allosteric, non-competitive and independent modulators of receptor-channel ensembles. Farmakologiia i Toksikologiia 48(5): 5-12

Ehlert, F.J. 1992: Allosterism and drug action. Proceedings of the Western Pharmacology Society 35: 215-219

Singh, D.; Tamao, Y.; Blakley, R.L. 1976: Allosterism, regulation and cooperativity: the case of ribonucleotide reductase of Lactobacillus leichmannii. Advances in Enzyme Regulation 15: 81-100

Johnson, B.A.; Bonaventura, C.; Bonaventura, J. 1988: Allostery in Callinectes sapidus hemocyanin: cooperative oxygen binding and interactions with L-lactate, calcium, and protons. Biochemistry 27(6): 1995-2001

Davis, B.D. 1988: Allostery, information and reductionism. Trends in Biochemical Sciences 13(10): 377-378

Nuñez, G.; Ball, E.J.; Myers, L.K.; Stastny, P. 1985: Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation. Immunogenetics 22(1): 85-91

Ryan, J.J.; LeJeune, H.B.; Mond, J.J.; Finkelman, F.D. 1991: Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen. Immunogenetics 34(2): 88-100

Rozendaal, L.; Pals, S.T.; Schilham, M.; Melief, C.J.; Gleichmann, E. 1989: Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes. European Journal of Immunology 19(9): 1669-1675

Nikitin, G.D.; Roskov, R.V.; Linnik, S.A. 1978: Allotendoplasty in Achilles tendon injuries. Vestnik Khirurgii Imeni I. I. Grekova 121(9): 107-110

Nikitin, G.D.; Efimov, V.H.; Khaĭmin, V.V.; Linnik, S.A. 1978: Allotendoplasty in injuries of the biceps muscle of the arm. Vestnik Khirurgii Imeni I. I. Grekova 120(6): 126-130

Nikitin, G.D.; Linnik, S.A.; Filippov, K.V. 1987: Allotendoplasty in rupture of the pectoralis major muscle. Ortopediia Travmatologiia i Protezirovanie 9: 47-48

Chanysheva, R.I.; Oleneva, V.A.; Redziuk, L.A.; Bakumenko, M.S.; Firsova, L.F. 1989: Allotment cards of dietetic dishes and a model 7-day menu for hospitals. Meditsinskaia Sestra 48(11): 40

Toyoshima, K.; Yamanashi, Y.; Inoue, K.; Katagiri, T.; Sukegawa, J.; Semba, K.; Yamamoto, T. 1990: Allotment of protein-tyrosine kinases belonging to the src-family. Advances in Second Messenger and Phosphoprotein Research 24: 284-289

Schwartz, O.; Andreasen, J.O. 1988: Allotransplantation and autotransplantation of mature teeth in monkeys: the influence of endodontic treatment. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 46(8): 672-681

Zaykova, M.V.; Lubnin, V.G.; Koroleva, J.V. 1989: Allotransplantation in mechanical eyelid injuries. Acta Chirurgiae Plasticae 31(2): 65-73

Shraer, T.I.; Abalmasov, G.M. 1976: Allotransplantation of cadaveric kidney. Urologiia i Nefrologiia 1: 21-24

Hegre, O.D.; Ketchum, R.J.; Popiela, H.; Eide, C.R.; Meloche, R.M.; Serie, J.R.; Moore, W.V. 1989: Allotransplantation of culture-isolated neonatal rat islet tissue. Absence of MHC class Ii positive antigen-presenting cells in nonimmunogenic islets. Diabetes 38(2): 146-151

Sarkisov, D.S.; Glushchenko, E.V.; Gurukov, S.R.; Morozov, S.S.; Tumanov, V.P.; Berezhkov, N.V. 1991: Allotransplantation of cultured fibroblasts on non-healing wounds after autodermatoplasty. Biulleten' Eksperimental'noi Biologii i Meditsiny 111(5): 542-544

Janssen de Limpens, A.M.; Cormane, R.H.; Siddiqui, A.H. 1978: Allotransplantation of cultured human skin. Archives of Dermatological Research 262(3): 323-328

Mshvidobadze, M.V. 1979: Allotransplantation of formalinized bones and articular ends in long tubular bone defects. Ortopediia Travmatologiia i Protezirovanie 3: 46-48

He, L. 1992: Allotransplantation of meniscus in dog's knee. An experimental study. Zhonghua Wai Ke Za Zhi 30(1): 21-24; 62

Serie, J.R.; Hegre, O.D. 1987: Allotransplantation of neonatal islets in nonimmunosuppressed normal and diabetic rats. Transplantation Proceedings 19(1 Part 2): 962-964

Zeng, Q. 1986: Allotransplantation of parathyroid glands to treat intractable hypoparathyroidism. Surgery 99(1): 131-132

Gross, A.E.; Langer, F.; Houpt, J.; Pritzker, K.; Friedlaender, G. 1976: Allotransplantation of partial joints in the treatment of osteoarthritis of the knee. Transplantation Proceedings 8(2 Suppl 1: 129-132

Iablokova, V.I.; Arutiunova, E.V.; Fedorovich, O.K.; Kurzin, V.S. 1977: Allotransplantation of preserved endometrium as a method of treating the uterine form of amenorrhea of post-tubercular origin. Akusherstvo i Ginekologiia 1: 59-60

Lee, H.C.; Ahn, K.J.; Lim, S.K.; Kim, K.R.; Ahn, Y.S.; Lee, K.E.; Huh, K.B. 1992: Allotransplantation of rat islets into the cisterna magna of streptozotocin-induced diabetic rats. Transplantation 53(3): 513-516

Kukreja, S.C.; Johnson, P.A.; Ayala, G.; Bowser, E.N.; Williams, G.A. 1979: Allotransplantation of rat parathyroid glands: effects of organ culture and transplantation into the adrenal gland. Experientia 35(4): 559-560

Banchini, E.; Contini, S.; Ovaleo Pandolfo, E. 1975: Allotransplantation of the duodeno-pancreatic block in the rat: note on the surgical technic. L'Ateneo Parmense. Acta Bio-Medica: Organo Della Societa di Medicina e Scienze Naturali di Parma 46(4): 247-254

Kiprenskiĭ, I.V. 1976: Allotransplantation of the lung and its lobes experimentally and clinically. Grudnaia Khirurgiia 4: 94-99

Salem, G.; Schlick, W.; Keiler, A.; Möschl, P.; Glöckler, M.; Radaszkiewicz, T.; Kreuzer, W. 1979: Allotransplantation of the lung in dogs with experimental lung damage. World Journal of Surgery 3(4): 511-514

Blumenstock, D.A.; Cannon, F.D.; Franck, W.A.; Hales, C.A.; Kazemi, H.; Ferrebee, J.W. 1977: Allotransplantation of the lung without immunosuppression after transplantation. II. Combined autotransplantation of bone marrow and allotransplantation of lung. Transplantation 24(3): 194-200

Kapustina, T.M.; Orlov, V.N. 1977: Allotransplantation of tubular fragments of the tibial diaphysis at various levels in an experiment. Ortopediia Travmatologiia i Protezirovanie 7: 37-40

Rokhlin, O.V.; Nezlin, R.S.; Machulla, H.K. 1975: Allotype ratio in isoelectric fractions of anti-azobenzoate antibodies from heterozygous rats. a distinct fraction with absolute allotypic predominance in all individual rats. Immunochemistry 12(4): 311-315

Gilman-Sachs, A.; Eskinazi, D.P.; Dray, S. 1977: Allotype suppression at the CHn locus of IgM in heterozygous rabbits with concomitant suppression at the VHa locus of all Ig classes. Journal of Immunology 119(4): 1369-1373

Connell, G.E.; Dubiski, S. 1977: Allotype suppression in rabbits: the requirement for CH3 domain of anti-allotype antibody. Journal of Immunology 119(2): 540-542

Sarvas, H.; Rautonen, N.; Mäkelä, O. 1991: Allotype-associated differences in concentrations of human IgG subclasses. Journal of Clinical Immunology 11(1): 39-45

Ermel, R.; Kenny, T.; Benisek, W.; Roberts, M.; Robbins, D. 1992: Allotype-dependent stimulation of peripheral blood and synovial lymphocytes by IgG3 in rheumatoid arthritis. Clinical Immunology and Immunopathology 63(3): 259-266

Nakashima, I.; Isobe, K.; Yoshida, T.; Iwamoto, T.; Nagase, F.; Zhang, Y.H.; Pu, M.; Lwin, T. 1991: Allotype-linked immune response genes: roles in network control of the immune system. Experimental and Clinical Immunogenetics 8(3): 121-139

Bowen, M.B.; Bellone, C.J. 1987: Allotype-linked production of an idiotype-specific factor that promotes idiotype expression in nonresponder strains. Journal of Immunology 139(6): 1780-1785

Press, J.L.; McDevitt, H.O. 1977: Allotype-specific analysis of anti-(Tyr,Glu)-Ala-Lys antibodies produced by Ir-1A high and low responder chimeric mice. Journal of Experimental Medicine 146(6): 1815-1820

Morris, S.C.; Cheek, R.L.; Cohen, P.L.; Eisenberg, R.A. 1990: Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. Journal of Immunology 144(3): 916-922

McCartney-Francis, N.; Young-Cooper, G.; Alexander, C.; Mage, R.G. 1986: Allotype-specific probes. a molecular approach to the study of serologically defined determinants. Journal of Immunological Methods 93(2): 149-155

De Lange, G.G. 1991: Allotypes and other epitopes of immunoglobulins. Bailliere's Clinical Haematology 4(4): 903-925

Goding, J.W. 1978: Allotypes of IgM and IgD receptors in the mouse: a probe for lymphocyte differentiation. Contemporary Topics in Immunobiology 8: 203-243

Hobart, M.J.; Lachmann, P.J. 1976: Allotypes of complement components in man. Transplantation Reviews 32: 26-42

Beckers, A.; Bazin, H. 1975: Allotypes of rat immunoglobulins--III: an allotype of the gamma2b-chain locus. Immunochemistry 12(8): 671-675

Mitichashvili, R.S.; Kochlashvili, T.I.; Mirtskhulava, E.G.; Savina, M.A.; Ermolaev, V.I. 1988: Allotypes of swine serum proteins. Genetika 24(9): 1665-1670

Harindranath, N.; Lamoyi, E.; Mage, R.G. 1989: Allotypes of the constant region of the rabbit T cell receptor beta-2 chain. Journal of Immunology 142(9): 3292-3297

Bordenave, G.R. 1977: Allotypic and idiotypic specificities of anti-Salmonella abortus-equi antibodies produced in rabbits with successive sublethal irradiation. Annales d'Immunologie 128(1-2): 169-171

Gilman-Sachs, A.; Dray, S. 1985: Allotypic and isotypic specificities of rabbit IgM: localization to the Fab mu or Fc mu fragments. Molecular Immunology 22(1): 57-65

Schreier, P.H.; Quester, S.; Bothwell, A. 1986: Allotypic differences in murine mu genes. Nucleic Acids Research 14(5): 2381-2389

van Loghem, E. 1986: Allotypic markers. Monographs in Allergy 19: 40-51

Grosse-Wilde, H.; Doxiadis, I. 1989: Allotyping for HLA class i using plasma as antigen source. Journal of Immunogenetics 16(2): 149-155

Ropartz, C. 1975: Allotypy of human immunoglobulins. Maroc Medical 55(588): 160

Zellmer, W.A. 1987: Allow no harm. American Journal of Hospital Pharmacy 44(9): 2033

Nyman, K. 1992: Allow proposal for family physicians to mature!. Vardfacket 16(14): 3

Ertl, P. 1992: Allow the ulcer to heal. Treatment of leg ulcers. Professional Nurse 7(6): 406-412

Meyer, F.H. 1975: Seated work and a prone patient. Der Zahnarzt; Colloquium Med. Dent 19(4): 129-131

Petrov, I.A.; Kovaleva, E.A.; Petrova, T.A. 1986: Allowable duration for using intrauterine polyethylene contraceptives. Akusherstvo i Ginekologiia 7: 40-41

Zhuchenko, A.A.; Korol', A.B.; Andriushchenko, V.K. 1978: Allowance for interference when measuring the linkage between quantitative trait factors and marker loci. Tsitologiia i Genetika 12(5): 453-457

Eremchenko, M.A. 1979: Allowance for the nature of student movements in the planning decisions for school buildings. Gigiena i Sanitariia 1: 28-32

De Castro, B.T. 1976: Allowance for the school plan of the nursing auxiliary course. Revista Enfermagem Em Novas Dimensoes 2(4): 204-208

Shearwin, K.E.; Winzor, D.J. 1990: Allowance for thermodynamic nonideality and Donnan effects in binding studies. Activity coefficients of charged ligands in the presence of albumin. Biophysical Chemistry 36(3): 235-243

Bergman, D.A.; Winzor, D.J. 1987: Allowance for "analyte valence" in the retention model of ion-exchange chromatography. Studies of adenosine 5'-phosphates on DEAE cellulose. Journal of Chromatography 391(1): 67-77

Guillard, G. 1988: Allowances for complete loss of employment (2). Soins; la Revue de Reference Infirmiere 514: 59-60

Weaver, J.P. 1990: Allowing death. North Carolina Medical Journal 51(5): 238-239

Pierce, D.A.; Preston, D.L.; Stram, D.O.; Vaeth, M. 1991: Allowing for dose-estimation errors for the A-bomb survivor data. Journal of Radiation Research 32 Suppl: 108-121

Mason, P. 1992: Allowing for loss. Nursing Times 88(2): 14-15

Clouser, K.D. 1977: Allowing or causing: another look. Annals of Internal Medicine 87(5): 622-624

Read, M.S.; Vaughan, R.S. 1991: Allowing pre-operative patients to drink: effects on patients' safety and comfort of unlimited oral water until 2 hours before anaesthesia. Acta Anaesthesiologica Scandinavica 35(7): 591-595

Creighton, H. 1978: Allowing relatives to help patients. Law for the nurse supervisor. Supervisor Nurse 9(5): 104-109

Silverstein, H.R. 1988: Allowing the dying to die. Delaware Medical Journal 60(10): 579-580

Kane, J.J. 1992: Allowing the novice to succeed: transitional support in critical care. Critical Care Nursing Quarterly 15(3): 17-22

Truog, R.D. 1990: Allowing to die. Critical Care Medicine 18(7): 790-791

Idahl, L.A.; Lernmark, A.; Sehlin, J.; Täljedal, I.B. 1977: Alloxan cytotoxicity in vitro. Inhibition of rubidium ion pumping in pancreatic beta-cells. Biochemical Journal 162(1): 9-18

Grankvist, K.; Lernmark, A.; Täljedal, I.B. 1977: Alloxan cytotoxicity in vitro. Microscope photometric analyses of Trypan Blue uptake by pancreatic islet cells in suspension. Biochemical Journal 162(1): 19-24

Iams, S.G.; Wexler, B.C. 1977: Alloxan diabetes in spontaneously hypertensive rats: gravimetric, metabolic and histopathological alterations. British Journal of Experimental Pathology 58(2): 177-199

Boquist, L. 1989: Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity. Diabete and Metabolisme 15(1): 23-29

Högberg, J. 1975: Alloxan induced fatty liver degeneration in rat: its effect on the microsomal lipids. Experimental and Molecular Pathology 22(1): 20-28

Tse, S.S.; Edmonds, B.; Mamelok, R.D. 1985: Alloxan stimulates p-aminohippurate uptake in renal basal-lateral membranous vesicles. Biochimica et Biophysica Acta 814(2): 333-340

Gorus, F.K.; Finsy, R.; Pipeleers, D.G. 1986: Alloxan toxicity in human and canine spermatozoa. Possible biochemical basis for a species difference in sensitivity. Biochemical Pharmacology 35(10): 1725-1729

Reif, D.W.; Samokyszyn, V.M.; Miller, D.M.; Aust, S.D. 1989: Alloxan- and glutathione-dependent ferritin iron release and lipid peroxidation. Archives of Biochemistry and Biophysics 269(2): 407-414

Kimura, I.; Nakamura, T.; Kimura, M. 1988: Alloxan-diabetic state-induced suppression of Ca2+-dependent slow action potentials in mouse diaphragm muscle. Japanese Journal of Pharmacology 47(2): 197-199

Henquin, J.C.; Malvaux, P.; Lambert, A.E. 1979: Alloxan-induced alteration of insulin release, rubidium efflux and glucose metabolism in rat islets stimulated by various secretagogues. Diabetologia 16(4): 253-260

Watała, C.; Budziejewska, A.; Jóźwiak, Z. 1989: Alloxan-induced alterations in composition and dynamics of red blood cell membranes. I. Effect of alloxan on intact red blood cells and isolated erythrocyte membranes. Biochemical Pharmacology 38(11): 1793-1798

Mishra, G.; Behera, H.N. 1986: Alloxan-induced changes in the collagen characteristics in the skin of male garden lizards, Calotes versicolor, from three age groups. Archives of Gerontology and Geriatrics 5(1): 11-19

Pang, S.F.; Tang, F.; Tang, P.L. 1985: Alloxan-induced diabetes and the pineal gland: differential effects on the levels of pineal N-acetylserotonin, pineal melatonin, and serum melatonin. Journal of Pineal Research 2(1): 79-85

Jansson, L.; Sandler, S. 1986: Alloxan-induced diabetes in the mouse: time course of pancreatic B-cell destruction as reflected in an increased islet vascular permeability. Virchows Archiv. a Pathological Anatomy and Histopathology 410(1): 17-21

Lips, J.P.; Jongsma, H.W.; Eskes, T.K. 1988: Alloxan-induced diabetes mellitus in pregnant sheep and chronic fetal catheterization. Laboratory Animals 22(1): 16-22

Miodovnik, M.; Mimouni, F.; Berk, M.; Clark, K.E. 1989: Alloxan-induced diabetes mellitus in the pregnant ewe: metabolic and cardiovascular effects on the mother and her fetus. American Journal of Obstetrics and Gynecology 160(5 Part 1): 1239-1244

Heikkila, R.E.; Winston, B.; Cohen, G. 1976: Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochemical Pharmacology 25(9): 1085-1092

Murnane, J.M.; Ritter, S. 1985: Alloxan-induced glucoprivic feeding deficits are blocked by D-glucose and amygdalin. Pharmacology Biochemistry and Behavior 22(3): 407-413

Ingerman-Wojenski, C.M.; Smith, M.; Silver, M.J. 1987: Alloxan-induced hyperglycemia in rabbits and the response of platelets to aggregating agents in vitro and to exposed subendothelium in vivo. Thrombosis Research 46(5): 635-647

Lenzen, S.; Panten, U. 1988: Alloxan: history and mechanism of action. Diabetologia 31(6): 337-342

Schumann, E.; Keiner, P.; Klose, E. 1978: Alloy according to Wood, a radiologically interesting material for the self-production of individual collimators and radiation protective means. Radiobiologia Radiotherapia 19(1): 73-76

Hohmann, W. 1986: Alloy situation after zero hour. Thoughts on the new denture guidelines. Das Dental-Labor. le Laboratoire Dentaire. Dental Laboratory 34(8): 1225-1227

Rapani, C.; Caputi, S.; Petrelli, I.; Daddona, A.; Zucchi, E. 1990: Alloy telescopic crowns. Clinical indications. Dental Cadmos 58(13): 48-52

Zukunft, D. 1977: Alloy--a cobalt--chrome alloy from Russia. Zahntechnik; Zeitschrift für Theorie und Praxis der Wissenschaftlichen Zahntechnik 18(10): 449

Schulz, P. 1985: Tongue as a mirror of systemic diseases (II). Zwr 94(1): 32-36

Buzzanca, R. 1986: Alloys and corrosion. Stomatologia Mediterranea: Sm 6(2): 257-265

Quintero Englembright, M.A.; Barceló Santana, F.; Palma Calero, M. 1991: Alloys for metal-ceramics 3. Practica Odontologica 12(1): 21-25

Ersoy, A.E. 1989: Alloys of fixed partial dentures. Ankara Universitesi Dis Hekimligi Fakultesi Dergisi 16(3): 539-542

Roucoules, L. 1975: Alloys used in the dental arts. Le Chirurgien-Dentiste de France 45(271): 69-71 Concl

Levy, M.; Steiner, E.E.; Levin, D.A. 1975: Allozyme genetics in permanent translocation heterozygotes of the Oenothera biennis complex. Biochemical Genetics 13(7-8): 487-500

Mulley, J.C.; James, J.W.; Barker, J.S. 1979: Allozyme genotype--environment relationships in natural populations of Drosophila buzzatii. Biochemical Genetics 17(1-2): 105-126

Nemeth, S.T.; Tracey, M.L. 1979: Allozyme variability and relatedness in six crayfish species. Journal of Heredity 70(1): 37-43

Houle, D. 1989: Allozyme-associated heterosis in Drosophila melanogaster. Genetics 123(4): 789-801

Zamer, W.E.; Hoffmann, R.J. 1989: Allozymes of glucose-6-phosphate isomerase differentially modulate pentose-shunt metabolism in the sea anemone Metridium senile. Proceedings of the National Academy of Sciences of the United States of America 86(8): 2737-2741

Lindsey, S.W.; Evans, E.F. 1978: Allpurinol hypersensitivity syndrome: effects and treatment. Virginia Medical 105(4): 297-299

Goodman, D.H.; Harris, J. 1975: Allpyral: An appraisal. Annals of Allergy 35(1): 17-25

Wist, E. 1990: Alltime pain relief?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(5): 581

Swann, W.B.; Wenzlaff, R.M.; Krull, D.S.; Pelham, B.W. 1992: Allure of negative feedback: self-verification strivings among depressed persons. Journal of Abnormal Psychology 101(2): 293-306

Hooley, J.M.; Richters, J.E. 1992: Allure of self-confirmation: a comment on Swann, Wenzlaff, Krull, and Pelham. Journal of Abnormal Psychology 101(2): 307-309

Armstrong, M.S.; McConaghy, N. 1977: Allusive thinking, the Word Halo and verbosity. Psychological Medicine 7(3): 439-445

Silva, J.M.; O'Brien, P.J. 1989: Allyl alcohol- and acrolein-induced toxicity in isolated rat hepatocytes. Archives of Biochemistry and Biophysics 275(2): 551-558

Nizze, H.; Lapis, K.; Kovács, L. 1979: Allyl alcohol-induced changes in the rat exocrine pancreas. Digestion 19(6): 359-369

Ferrali, M.; Ciccoli, L.; Comporti, M. 1989: Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochemical Pharmacology 38(11): 1819-1825

Hayakawa, Y.; Kato, H.; Nobori, T.; Noyori, R.; Imai, J. 1986: Allyl and allyloxycarbonyl groups as versatile protecting groups in nucleotide synthesis. Nucleic Acids Symposium Series 17: 97-100

Anonymous 1985: Allyl chloride. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 36: 39-54

Anonymous 1985: Allyl isothiocyanate. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 36: 55-68

Neudecker, T.; Henschler, D. 1985: Allyl isothiocyanate is mutagenic in Salmonella typhimurium. Mutation Research 156(1-2): 33-37

Anonymous 1985: Allyl isovalerate. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 36: 69-74

Hayakawa, Y.; Hirose, M.; Noyori, R. 1990: Allyl protection of O6 position of 2'-deoxyguanosine. Nucleic Acids Symposium Series 22: 1-2

Kumar, D.; Hysmith, R.M.; Boor, P.J. 1990: Allylamine and beta-aminopropionitrile-induced vascular injury: an in vivo and in vitro study. Toxicology and Applied Pharmacology 103(2): 288-302

Boor, P.J.; Hysmith, R.M. 1987: Allylamine cardiovascular toxicity. Toxicology 44(2): 129-145

Cox, L.R.; Ramos, K. 1990: Allylamine-induced phenotypic modulation of aortic smooth muscle cells. Journal of Experimental Pathology 71(1): 11-18

Ramos, K.; Grossman, S.L.; Cox, L.R. 1988: Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. Toxicology and Applied Pharmacology 95(1): 61-71

Ganzinger, U.; Stutz, A.; Petranyi, G.; Stephen, A. 1986: Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents. Acta Dermato-Venereologica. Supplementum 121: 155-160

Harvey, D.J. 1977: Allyldimethylsilyl ethers as derivatives for the characterization of steroids and cannabinoids by combined gas chromatography and mass spectrometry. Biomedical Mass Spectrometry 4(4): 265-274

Phillipou, G. 1976: Allyldimethylsilyl ethers. new derivatives for the analysis of steroids by gas chromatography-mass spectrometry. Journal of Chromatography 129: 384-386

Thomas, J.; Yang, Y.C. 1991: Allylglycine-induced seizures in male and female rats. Physiology and Behavior 49(6): 1181-1183

Eder, E.; Lutz, D.; Jörns, M. 1987: Allylic compounds bind directly to DNA: investigation of the binding mechanisms in vitro. Chemico-Biological Interactions 61(2): 97-108

Anderson, W.K.; Dewey, R.H.; Mulumba, B. 1979: Allylic esters as potential antitumor agents. Derivatives and analogues of 2,3-bis(hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-ene. Journal of Medicinal Chemistry 22(10): 1270-1272

Holmes, B.N.; Leonard, N.J. 1976: Allylic rearrangement from O6 to N-3 and N-7 of guanine blocked at C-8. Journal of Organic Chemistry 41(3): 568-571

Baird, M.B.; Birnbaum, L.S.; Samis, H.B.; Massie, H.R.; Zimmerman, J.A. 1976: Allylisopropylacetamide preferentially interacts with the phenobarbital-inducible form of rat hepatic microsomal P-450. Biochemical Pharmacology 25(21): 2415-2417

Rovera, G.; Aden, D.; Surrey, S. 1978: Allylisopropylacetamide restricts expression of beta minor globin gene in Friend cells. Nature 272(5649): 172-175

Tanii, H.; Kurosaka, Y.; Hayashi, M.; Hashimoto, K. 1989: Allylnitrile: a compound which induces long-term dyskinesia in mice following a single administration. Experimental Neurology 103(1): 64-67

Choate, A.B. 1976: Allyn Blythe Choate, M.D. North Carolina Medical Journal 37(1): 58-59

Rasmussen, G. 1986: Help for the caregivers--pills or a course of burnout?. Sykepleien 73(20): 12-15; 21

Bryant, J.H.; Zuberi, R.W.; Thaver, I.H. 1991: Alma Ata and health for all by the year 2000. The roles of academic institutions. Infectious Disease Clinics of North America 5(2): 403-416

Kozhebekov, Z.K. 1977: Alma-Ata Zooveterinary Institute. Veterinariia 1977(11): 114-116

Donnelly, P.D. 1991: Alma-Ata and the privatisation of environmental health. Public Health 105(5): 349-350

Ahluwalia, J.S. 1985: Alma-Ata. Health care for all by the year 2000. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 137(11): 15-18

Pasturel, A.; Gigaut, C.; Pons, J. 1985: Alminoprofene for inflammatory lesions and surgical pain in oral medicine. Actualites Odonto-Stomatologiques 39(151): 507-512

Mihălţan, F. 1989: Almitrine (Vectarion)--an always up-to-date respiratory adjuvant. Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 38(2): 109-114

Lerebours, G.; Moore, N.; Senant, J. 1988: Almitrine and peripheral nerve function. Lancet 2(8614): 799-800

Suggett, A.J.; Jarratt, J.A.; Proctor, A.; Howard, P. 1985: Almitrine and peripheral neuropathy. Lancet 2(8459): 830-831

Olievier, C.N.; Berkenbosch, A.; DeGoede, J. 1989: Almitrine and the peripheral ventilatory response to CO2 in hyperoxia and hypoxia. Respiration Physiology 78(3): 391-402

Kauffmann, F. 1987: Almitrine as a long term treatment for chronic obstructive pulmonary disease. Bulletin Europeen de Physiopathologie Respiratoire 23(6): 667

Duroux, P. 1985: Almitrine bismesylate. Revue des Maladies Respiratoires 2(Suppl 1): S1-S2

Winkelmann, B.R.; Hertrich, F. 1987: Almitrine bismesylate and hypoxemia. Annals of Internal Medicine 106(1): 164

Vulterini, S.; Dardes, N.; Moreo, G.C.; Chianese, R.; Maiorano, V.; Carnimeo, N. 1986: Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial). European Journal of Respiratory Diseases. Suppl 146: 677-683

Evrard, Y. 1985: Almitrine bismesylate and ventilation-perfusion ratios. Revue des Maladies Respiratoires 2(Suppl 1): S17-S22

Wuttke, R.; von Wichert, P. 1985: Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration. Respiration; International Review of Thoracic Diseases 48(4): 285-295

Behm, R.; Szentmiklósi, A.J.; Cseppentö, A.; Szegi, J. 1987: Almitrine bismesylate modulates the susceptibility of guinea pig pulmonary artery to catecholamines, PGF2 alpha and adenosine. Biomedica Biochimica Acta 46(12): 953-958

Nielsen, S.P. 1988: Almitrine bismesylate. a peripheral chemoreceptor agonist. Ugeskrift for Laeger 150(46): 2797-2800

Voisin, C.; Howard, P.; Ansquer, J.C. 1987: Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group. Bulletin Europeen de Physiopathologie Respiratoire 23 Suppl. 11: 169s-182s

Tweney, J. 1987: Almitrine bismesylate: current status. Bulletin Europeen de Physiopathologie Respiratoire 23(Suppl 11): 153s-163s

Hervé, P.; Simonneau, G.; Duroux, P. 1988: Almitrine decreases compliance of pulmonary arteries in COPD. Chest 94(5): 1119-1120

Mihalţan, F. 1987: Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology. Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 36(3): 209-219

Préfaut, C.; Bourgouin-Karaouni, D. 1985: Almitrine dimesylate: ventilatory or vascular action. La Revue de Medecine Interne 6(Special Issue): 3-7

Daskalopoulou, E.; Patakas, D.; Tsara, V.; Kazis, A.; Maniki, E.; Zoglopitis, F. 1987: Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD). Bulletin Europeen de Physiopathologie Respiratoire 23(Suppl 11): 185s-190s

De Backer, W.; Vermeire, P.; Bogaert, E.; Janssens, E.; Van Maele, R. 1985: Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction. Bulletin Europeen de Physiopathologie Respiratoire 21(5): 427-432

Connaughton, J.J.; Douglas, N.J.; Morgan, A.D.; Shapiro, C.M.; Critchley, J.A.; Pauly, N.; Flenley, D.C. 1985: Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema. American Review of Respiratory Disease 132(2): 206-210

Anonymous 1985: Almitrine in chronic airflow obstruction. Lancet 1(8432): 796-797

Bourgouin-Karaouni, D.; Préfaut, C. 1985: Almitrine in daily practice. La Revue de Medecine Interne 6(Special Issue): 15-20

Maxwell, D.L.; Cover, D.; Hughes, J.M. 1985: Almitrine increases the steady-state hypoxic ventilatory response in hypoxic chronic air-flow obstruction. American Review of Respiratory Disease 132(6): 1233-1237

Gherardi, R.; Baudrimont, M.; Gray, F.; Louarn, F. 1987: Almitrine neuropathy. a nerve biopsy study of 8 cases. Acta Neuropathologica 73(2): 202-208

Kay, B.; Pollard, B.J. 1988: Almitrine temporarily suppresses respiratory depression caused by buprenorphine. Annales Francaises d'Anesthesie et de Reanimation 7(2): 176-177

Rigoulet, M.; Ouhabi, R.; Leverve, X.; Putod-Paramelle, F.; Guérin, B. 1989: Almitrine, a new kind of energy-transduction inhibitor acting on mitochondrial ATP synthase. Biochimica et Biophysica Acta 975(3): 325-329

Gherardi, R.; Bélec, L.; Louarn, F. 1989: Almitrine-induced peripheral neuropathy and weight loss. Journal of Neurology 236(6): 374

Poitrenaud, J.; Piette, F.; Malbezin, M.; Sebban, C.; Guez, D. 1990: Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study. Clinical Neuropharmacology 13(Suppl 3): S100-S108

Rubio Terrés, C.; López Alvarez, M.; Vargas Castrillón, E. 1990: Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease. Revista Clinica Espanola 186(2): 84-87

Melinder, K.; Nygren, A.; Skjönberg, G.; Svanström, L. 1990: Almost 3 million fatal injuries are caused by accidents yearly. Lakartidningen 87(36): 2789

Mokros, W.; Schultz, M.; Biebl, M. 1990: Almost 40 years' survival with the "Biebl stomach". Zentralblatt für Chirurgie 115(6): 359-363

Elliott, J. 1979: Almost a reality: prediction of drug effects on human cancers. JAMA 242(6): 501

Hayashi, K.; Maruyama, T.; Nakatsuru, K.; Nakamura, H.; Kitamura, T.; Shigehira, M.; Tsuda, K.; Hidaka, Y. 1987: Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(9): 2775-2778

Sasaki, U.; Itagaki, T.; Shimizu, H.; Takahashi, M. 1976: Almost complete regression of cerebral arteriovenous malformation--report of a case. No Shinkei Geka. Neurological Surgery 4(2): 175-181

Holyoke, E.A.; Holyoke, E.A. 1979: Almost fifty years; over fifty classes--a salute to a teacher (Edward A. Holyoke). Nebraska Medical Journal 64(6): 168-169

Walder, B. 1988: Almost like home... KRANKENPFLEGE. Soins Infirmiers 81(12): 84-89

Woodward, R. 1986: Almost like the real thing. New Zealand Nursing Journal. Kai Tiaki 79(1): 22-23

Mosey, C. 1989: Almost paradise. Registered Nurse 1(2): 15-19

Schreiber, M.H. 1989: Almost perfect. Investigative Radiology 24(2): 162

Numbers, R.L. 1978: Almost persuaded. American physicians and compulsory health insurance, 1912-1920. Henry E. Sigerist supplements to the Bulletin of the history of medicine 1978(1): 1-158

Mietens, C. 1986: Almost simultaneous occurrence of varicella and zoster in an otherwise healthy child. Pediatric Infectious Disease 5(4): 482-483

Salazar, J.; Alonso-Lej, F.; Plaza, L.; Gutierrez, A.; Garcia, M.D.; Ibarra, F.; Felipe, J. 1986: Almost total absence of the left ventricular myocardium with dextro-transposition of the great arteries. Pediatric Cardiology 6(5): 283-285

Ricotti, G.C.; Apicella, P.; Macconi, A.; Parisi, L.; Martini, R.; Consumi, I. 1989: Alobar holoprosencephaly. Prenatal diagnosis and autopsy findings in 2 cases. Pathologica 81(1076): 635-642

Pusch, H.J. 1978: Alochol-induced pancreas diseases. Medizinische Klinik 73(28-29): 1039-1049

Kaufman, T.; Newman, A.R.; Wexler, M.R. 1989: Aloe vera and burn wound healing. Plastic and Reconstructive Surgery 83(6): 1075-1076

Davis, R.H.; Maro, N.P. 1989: Aloe vera and gibberellin. Anti-inflammatory activity in diabetes. Journal of the American Podiatric Medical Association 79(1): 24-26

Crowell, J.; Hilsenbeck, S.; Penneys, N. 1989: Aloe vera does not affect cutaneous erythema and blood flow following ultraviolet B exposure. Photo-Dermatology 6(5): 237-239

Kivett, W.F. 1989: Aloe vera for burns. Plastic and Reconstructive Surgery 83(1): 195

Kaufman, T.; Kalderon, N.; Ullmann, Y.; Berger, J. 1988: Aloe vera gel hindered wound healing of experimental second-degree burns: a quantitative controlled study. Journal of Burn Care and Rehabilitation 9(2): 156-159

Frumkin, A. 1989: Aloe vera, salicylic acid, and aspirin for burns. Plastic and Reconstructive Surgery 83(1): 196

Shelkovitz-Shilo, I.; Kaplan, B.; Yorav, S. 1990: Aloe vera--the real truth. Harefuah 118(4): 228-229

Shelton, R.M. 1991: Aloe vera. its chemical and therapeutic properties. International Journal of Dermatology 30(10): 679-683

Yonge, O. 1990: Aloha clinical rotation in Hawaii. Canadian Nurse 86(3): 26-28

Kreutzberg, G.W.; Gudden, W.; Alzheimer, A. 1988: Alois Alzheimer. Trends in Neurosciences 11(6): 256-257

Hoff, P.; Hippius, H.; Alzheimer, A. 1989: Alois Alzheimer 1864-1915. An overview of his life and work on the occasion of his 125th birthday. Der Nervenarzt 60(6): 332-337

Tonkonogy, J.; Moak, G.S.; Alzheimer, A. 1988: Alois Alzheimer on presenile dementia. Journal of Geriatric Psychiatry and Neurology 1(4): 199-206

Sonntag, M.; Alzheimer, A. 1989: Alois Alzheimer--recognition of his scientific contribution and his influence on current dementia research. Zeitschrift für Arztliche Fortbildung 83(12): 645-649

Porter, J.M.; Seaman, A.J.; Common, H.H.; Rösch, J.; Eidemiller, L.R.; Calhoun, A.D. 1975: Comparison of heparin and streptokinase in the treatment of venous thrombosis. American Surgeon 41(9): 511-519

Owens, T.K. 1990: Alone at last. Nursing 20(4): 114-116

Hill, D. 1991: Alone out there. Nursing 21(8): 43

Magnusson, L. 1985: Alone with your God. a midwife reminisces. Jordemodern 98(1-2): 29-35

Adler, G.; Buie, D.H. 1979: Aloneness and borderline psychopathology: the possible relevance of child development issues. International Journal of Psycho-Analysis 60(1): 83-96

Peterson, C.A. 1992: Aloneness and the Isakower phenomenon. Journal of the American Academy of Psychoanalysis 20(1): 99-113

Ricci, M.S. 1991: Aloneness in tenuous self-states. Perspectives in Psychiatric Care 27(2): 7-11

Nilsson-Ehle, H.; Bremell, T.; Mobacken, H.; Norrsell, K.; Rödjer, S. 1990: Along the Silk Road and in Sweden. Behçet's syndrome--a rare systemic disease affecting mostly younger persons. Lakartidningen 87(41): 3311-3314

Corrigan, A. 1976: Along the bumpy path from 'double trouble' to 'twice as nice'. Australian Nurses' Journal. Royal Australian Nursing Federation 6(3): 25-27

Crede, W.B.; Hierholzer, W.J. 1988: Along the data-information continuum: pitfalls and opportunities. Infection Control and Hospital Epidemiology 9(4): 166-169

Bleeg, H.S.; Reinholdt, J.; Kilian, M. 1985: Bacterial immunoglobulin a proteases monitored by continuous spectrophotometry. Febs Letters 188(2): 357-362

Petrov, P.P. 1976: Along the true path of friendship and cooperation of Bulgarian and Soviet parasitological science and practice. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(3): 360-362

Palsbo, S. 1991: Along with Greenland's separation. Sygeplejersken 91(46): 10

Thompson, J.S. 1989: Alopecia after ileal pouch-anal anastomosis. Diseases of the Colon and Rectum 32(6): 457-465

Chan-Lam, D.; Fitzsimons, E.J.; Douglas, W.S. 1987: Alopecia after immunoglobulin infusion. Lancet 1(8547): 1436

Voron, D.A. 1988: Alopecia and amphetamine use. JAMA 260(2): 183-184

Kanwar, A.J.; Ghosh, S.; Thami, G.P.; Kaur, S. 1992: Alopecia and cutis verticis gyrata due to traction presenting as headache. International Journal of Dermatology 31(9): 671-672

Shelley, E.D.; Shelley, W.B. 1985: Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. Cutis 35(2): 148-149

Barth, J.H. 1988: Alopecia and hirsuties. Current concepts in pathogenesis and management. Drugs 35(1): 83-91

Warner, E.A.; Gresh, J.P. 1991: Alopecia and rash in a chronically ill woman. Hospital Practice 26(3a): 47-48

Dardour, J.C. 1978: Alopecia and skin grafts. Annales de Chirurgie Plastique 23(4): 231-233

Carter, D.M.; Jegasothy, B.V. 1976: Alopecia areata and down syndrome. Archives of Dermatology 112(10): 1397-1399

Young, E.; Bruns, H.M.; Berrens, L. 1978: Alopecia areata and atopy. Dermatologica 156(5): 306-308

Valsecchi, R.; Imberti, G.; Martino, D.; Cainelli, T. 1992: Alopecia areata and interleukin-2 receptor. Dermatology 184(2): 126-128

Orecchia, G. 1987: Alopecia areata and measles. Journal of the American Academy of Dermatology 17(5 Part 1): 840-841

Borroni, G. 1992: Alopecia areata and moral judgment in the history of art. American Journal of Dermatopathology 14(2): 170-173

Rosin, M.A. 1985: Alopecia areata and pemphigus foliaceus. Journal of the American Academy of Dermatology 12(5 Part 1): 895-896

Bovenmyer, D.A. 1977: Alopecia areata and regrowth of hair. Archives of Dermatology 113(12): 1732-1733

Schonwetter, R.S.; Nelson, E.B. 1986: Alopecia areata and the acquired-immunodeficiency-syndrome-related complex. Annals of Internal Medicine 104(2): 287

De Padova, M.P.; Guerra, L. 1988: Alopecia areata and thyroid diseases. Medicina 8(2): 185-187

Orecchia, G.; Perfetti, L. 1991: Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not. British Journal of Dermatology 124(5): 509

Pigatto, P.D.; Gini, R.; Altomare, G.F. 1985: Alopecia areata and treatment with the diethylester of squaric acid. Behavior of lymphocyte subpopulations. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 120(3): 227-230

Brown, A.C.; Olkowski, Z.L.; McLaren, J.R.; Kutner, M.H. 1977: Alopecia areata and vitiligo associated with Down's syndrome. Archives of Dermatology 113(9): 1296

Hazar, S.; Kaya, A. 1989: Alopecia areata as a potential adverse effect of orthodontic appliances: a case report. Quintessence International 20(12): 917-918

De Padova, M.P.; Veronesi, S.; Andriani, G.C.; Minghetti, G. 1987: Alopecia areata associated with onychodystrophy, vitiligo and lichen ruber planus. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 122(4): 191-192

Silvestri, A.; Santonastaso, P.; Paggiarin, D. 1988: Alopecia areata during lithium therapy. A case report. General Hospital Psychiatry 10(1): 46-48

Baron, J.; Zabel, J. 1989: Alopecia areata in a woman with marked hypoandrogenism. Przeglad Dermatologiczny 76(2): 133-136

Teillac, D. 1988: Alopecia areata in children. Annales de Pediatrie 35(5): 327-330

Insler, M.S.; Helm, C.J. 1989: Alopecia areata including the cilia and brows of two sisters. Annals of Ophthalmology 21(12): 451-453

Telli, A.E.; Enacar, A.; Biberci, P. 1990: Alopecia areata is an idiopathic disorder in which there is a rapidly developing loss of hair that usually begins on the scalp. Turk Ortodonti Dergisi: Ortodonti Derneg'nin Resmi Yayin Organidir 3(1): 157-158

Hehir, M.E.; du Vivier, A. 1979: Alopecia areata treated with DNCB. Clinical and Experimental Dermatology 4(3): 385-387

Hull, S.M.; Cunliffe, W.J.; Norris, J.F. 1990: Alopecia areata treated with diphencyprone: is an allergic response necessary?. British Journal of Dermatology 122(5): 716-717

Lamminger, C.; Näher, H. 1990: Alopecia areata universalis in Werlhof disease. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 41(6): 324-325

Du Vivier, A.; Munro, D.D. 1975: Alopecia areata, autoimmunity, and Down's syndrome. British Medical Journal 1(5951): 191-192

Van Joost, T.; Peereboom-Wynia, J.D.; Stolz, E.; Prins, M.E. 1987: Alopecia areata, clinical and immunological aspects. Nederlands Tijdschrift Voor Geneeskunde 131(13): 519-523

Milgraum, S.S.; Mitchell, A.J.; Bacon, G.E.; Rasmussen, J.E. 1987: Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. Journal of the American Academy of Dermatology 17(1): 57-61

Broniarczyk-Dyła, G. 1990: Alopecia areata--clinical and immunological characteristics. Przeglad Dermatologiczny 77(5): 363-366

Tosti, A.; Bardazzi, F.; Salardi, S.; Zauli, D. 1986: Alopecia areata. a clinical, immunologic and therapeutic study in a childhood population. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(4): 261-262

Price, V.H. 1991: Alopecia areata: clinical aspects. Journal of Investigative Dermatology 96(5): 68s

Hamm, H. 1991: Alopecia areata. Causes and possibilities of therapy. Medizinische Monatsschrift für Pharmazeuten 14(1): 2-4

Trevisan, G.; Cisilin, M.P. 1988: Alopecia areata. Hemorheological study and treatment with pentoxifylline. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 123(5): 211-214

Baadsgaard, O. 1991: Alopecia areata: an immunologic disease?. Journal of Investigative Dermatology 96(5): 89S-90S

Cipriani, R.; Bordin, A.; Veller Fornasa, C.; Coghi, P.; Costantini, G.; Peserico, A. 1989: Alopecia areata: appropriateness of various laboratory parameters. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 124(6): 265-266

Price, V.H. 1991: Alopecia areata: clinical aspects. Journal of Investigative Dermatology 96(5): 68s

Fiedler, V.C. 1991: Alopecia areata: current therapy. Journal of Investigative Dermatology 96(5): 69s-70s

Klaber, M.R.; Munro, D.D. 1978: Alopecia areata: immunofluorescence and other studies. British Journal of Dermatology 99(4): 383-386

Lozano de Luaces, V.; Espías Gómez, A.; Murtra Ferré, J.; Ruano Gil, D. 1988: Alopecia areata: review and presentation of some clinical cases. Avances en Odontoestomatologia 4(6): 273-279

Happle, R.; Echternacht, K. 1977: Alopecia areata: successful half-side treatment with DNCB. Zeitschrift für Hautkrankheiten 52(22): 1129-1134

Perret, C.M.; Steijlen, P.M.; Happle, R. 1989: Alopecia areata; pathogenesis and topical immunotherapy. Nederlands Tijdschrift Voor Geneeskunde 133(25): 1256-1260

Eilers, J. 1989: Alopecia article well received. Oncology Nursing Forum 16(2): 155-156

McElvaney, N.G.; Fielding, J.F.; O'Keane, J.C.; Fennelly, J.J. 1988: Alopecia as a presenting complaint in non-Hodgkin's lymphoma with hair regrowth on chemotherapy. Irish Journal of Medical Science 157(4): 115-116

Meyer, H.C. 1979: Alopecia associated with ibuprofen. JAMA 242(2): 142

Harris, P.L. 1986: Alopecia associated with long-term metyrapone use. Clinical Pharmacy 5(1): 66-68

Toussaint, D.; Ledoux, M.; Bruneau, N. 1978: Alopecia associated with macular retinal degeneration. Bulletin de la Societe Belge d'Ophtalmologie 180: 33-43

Neuman, K.M.; Burnett, J.W. 1985: Alopecia associated with syringomas. Journal of the American Academy of Dermatology 13(3): 528-529

Burket, J.M. 1987: Alopecia associated with underlying nerve sheath myxoma. Journal of the American Academy of Dermatology 16(1 Part 2): 209-211

Solomon, A.R. 1992: Alopecia by a different name. a matter of splitting hairs. Archives of Dermatology 128(1): 102-103

Franssen, C.F.; Hillen, H.F. 1991: Alopecia caused by cytostatic agents. Nederlands Tijdschrift Voor Geneeskunde 135(24): 1070-1073

Krivokhizh, V.N.; Odintsov, A.I. 1978: Alopecia caused by tuberculostatic drugs of the isonicotinic acid hydrazide group (HINA). Vestnik Dermatologii i Venerologii 3: 63-65

Taïeb, A. 1991: Alopecia circumscripta. Diagnostic orientation. La Revue du Praticien 41(26): 2773-2776

Okamura, M.; Mitsumoto, Y. 1976: Alopecia due to local pressure and its prevention. Nursing Technique 22(10): 174-177

Holmes, W. 1979: Alopecia from chemotherapy: can nursing measures help?. American Nurses Association Publications 1979(Np-59): 223-233

Atton, A.V.; Tunnessen, W.W. 1990: Alopecia in children: the most common causes. Pediatrics in Review 12(1): 25-30

Krause, K.H.; Flemming, M.; Scheglmann, K. 1987: Alopecia in meralgia paraesthetica. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(8): 474-476

Aranoff, S.M.; Levy, H.B.; Tuchman, A.J.; Daras, M. 1985: Alopecia in meralgia paresthetica. Journal of the American Academy of Dermatology 12(1 Part 2): 176-178

Resnick, S. 1976: Alopecia in pet skunks. Veterinary Medicine Small Animal Clinician: Vm Sac 71(10): 1475-1478

Siemund, J. 1985: Alopecia in vulgar psoriasis of the scalp. A clinical and histologic report. Dermatologische Monatschrift 171(1): 50-57

Pesce, A.; Cassuto, J.P.; Joyner, M.V.; Dujardin, P.; Audoly, P. 1978: Alopecia induced by oncostatic drug therapy: prevention by pneumatic head band. La Nouvelle Presse Medicale 7(16): 1399

Raznatovskiĭ, I.M.; Moshkalova, I.A. 1987: Alopecia mucinosa and skin lymphoma. Vestnik Dermatologii i Venerologii 5: 35-41

Soto Melo, J.; Contreras Rubio, F.; Patron Romero, M.; Casado Jiménez, M.; Fonseca Capdevila, E. 1979: Alopecia mucinosa associated with mycosis fungoides. Actas Dermo-Sifiliograficas 70(9-10): 575-584

Sentis, H.J.; Willemze, R.; Scheffer, E. 1988: Alopecia mucinosa progressing into mycosis fungoides. a long-term follow-up study of two patients. American Journal of Dermatopathology 10(6): 478-486

Archer, C.B.; Smith, N.P. 1990: Alopecia neoplastica responsive to tamoxifen. Journal of the Royal Society of Medicine 83(10): 647-648

Lesclous, P.; Maman, L. 1991: Alopecia of dental origin. Apropos of a case. L' Information Dentaire 73(39): 3443-3446

Fraunfelder, F.T.; Meyer, S.M.; Menacker, S.J. 1990: Alopecia possibly secondary to topical ophthalmic beta-blockers. JAMA 263(11): 1493-1494

Schultz-Ehrenburg, U.; Thies, W. 1975: Alopecia scleratrophicans carcinomatosa in metastasizing carcinoma of the breast. Zeitschrift für Hautkrankheiten 50(4): 141-146

Gorlin, R.J.; Cervenka, J. 1975: Alopecia totalis, nail dysplasia and amelogenesis imperfecta. Birth Defects Original Article Series 11(5): 23-24

Redmond, W.J. 1979: Alopecia universalis. Archives of Dermatology 115(5): 642

Monk, B. 1986: Alopecia universalis and Kallman's syndrome. Dermatologica 173(2): 101-102

Imam, K.; Abdullah, M.; Felicetta, J.V. 1988: Alopecia universalis as a feature of polyglandular autoimmunity type i. Western Journal of Medicine 149(3): 338-341

Lafeuillade, A.; Quilichini, R.; Chaffanjon, P.; Dhiver, C.; Gastaut, J.A. 1990: Alopecia universalis in a homosexual man seropositive for the human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes 3(10): 1019

Garty, B.Z.; Kauli, R. 1990: Alopecia universalis in autoimmune polyglandular syndrome type i. Western Journal of Medicine 152(1): 76-77

Shelley, W.B.; Wood, M.G. 1976: Alopecia with fibrous dysplasia and osteomas of skin. a sign of polyostotic fibrous dysplasia. Archives of Dermatology 112(5): 715-719

Gupta, P.C.; Patwari, A.K.; Mullick, D.N. 1990: Alopecia with rickets: an end organ unresponsiveness to 1,25-dihydroxyvitamin D--a case report. Indian Journal of Medical Sciences 44(9): 239-243

Starzl, T.E.; Putnam, C.W.; Groth, C.G.; Corman, J.L.; Taubman, J. 1975: Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. American Journal of Surgery 129(5): 587-590

Ioniţescu, C.; Popa, C.; Ionescu, A.; Cotescu, I. 1986: Alopecia, corneal dystrophy and congenital cataract. Familial cases. Revista de Chirurgie Oncologie Radiologie O. R. L. Oftalmologie Stomatologie. Seria: Oftalmologie 30(1): 71-74

Camacho Martínez, F. 1992: Alopecia, curable or incurable?. Medicina Clinica 99(3): 100-102

Piérard-Franchimont, C.; Piérard, G.E. 1987: Alopecia, diagnosis and treatment. Revue Medicale de Liege 42(13-14): 633-638

Pridmore, C.; Baraitser, M.; Brett, E.M. 1992: Alopecia, mental retardation, epilepsy and microcephaly in two cousins. Clinical Dysmorphology 1(2): 79-84

Koh, H.K.; Laub, D.A.; Tahan, S.R.; Gonzalez, E. 1986: Alopecia, photosensitivity, and arthritis. Archives of Dermatology 122(12): 1435; 1438

Egle, U.T.; Tauschke, E. 1987: Alopecia--a psychosomatic disease picture? I. Review of the literature. Psychotherapie Psychosomatik Medizinische Psychologie 37(1): 31-35

Johnston, K.; Golabi, M.; Hall, B.; Ito, M.; Grix, A. 1987: Alopecia-anosmia-deafness-hypogonadism syndrome revisited: report of a new case. American Journal of Medical Genetics 26(4): 925-927

Millikan, L.E. 1976: Alopecia: a systematic appraoch to diagnosis and therapy. Journal of Family Practice 3(3): 313-317

Rosanove, R. 1979: Alopecia: an increasing problem. Medical Journal of Australia 2(6): 308

Birnbaum, P.S.; Arndt, K.A. 1986: Alopecia: common and uncommon. Hospital Practice 21(5a): 19; 23 26-27

Olsen, E.A. 1989: Alopecia: evaluation and management. Primary Care 16(3): 765-787

Bergfeld, W.F. 1989: Alopecia: histologic changes. Advances in Dermatology 4: 301

Austin, V.H. 1979: Alopecias of the dog and cat. Modern Veterinary Practice 60(1): 35-39

Bastecký, J.; Podrouzek, V.; Vinar, O. 1978: Alosteric changes in plasma proteins in healthy volunteers after administration of lysergamide. Activitas Nervosa Superior 20(1): 82

Taylor, E.W. 1992: Alpbach workshop on the dynamics of motile systems, 4-10 April 1992. Journal of Muscle Research and Cell Motility 13(5): 581

Tommasi, M.; Jouvet-Telinge, A.; Kopp, N.; Pialat, J.; Gilly, J. 1977: Alpers' infantile cerebral poliodystrophy. a case with abnormal hepatic pyruvate carboxylase. Annales d'Anatomie Pathologique 22(4): 337-342

Mafee, M.F.; Meyer, D.H.; Hill, J.H. 1985: Neuroradiologic evaluation of patients with central auditory lesions. Otolaryngologic Clinics of North America 18(2): 223-239

Di Rienzo, A.; Felicetti, L.; Noveletto, A.; Colombo, B.; Bianco, I.; Brancati, C. 1987: Alpha +-thalassemia haplotypes in Italy. Birth Defects Original Article Series 23(5a): 39-42

Eshel, G.; Ross, S.B.; Kelder, D.; Edis, L.E.; Jackson, D.M. 1990: Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice. Pharmacology and Toxicology 67(2): 123-131

Michel, M.C.; Hanft, G.; Gross, G. 1990: Alpha 1 B- but not alpha 1 A-adrenoceptors mediate inositol phosphate generation. Naunyn-Schmiedeberg's Archives of Pharmacology 341(4): 385-387

Johnson, M.D.; Wray, A. 1990: Alpha 1 adrenergic receptor function in senescent Fischer 344 rat aorta. Life Sciences 46(5): 359-366

Rosenbaum, J.S.; Azhar, S.; Hoffman, B.B. 1987: Alpha 1 adrenergic receptor mediated polyphosphoinositide breakdown in DDT1-MF2 cells. Lack of evidence of desensitization after prolonged exposure to epinephrine. Biochemical Pharmacology 36(24): 4335-4340

Shapiro, E.; Lepor, H. 1987: Alpha 1 adrenergic receptors in canine lower genitourinary tissues: insight into development and function. Journal of Urology 138(4 Part 2): 979-983

Braszko, J.J.; Wiśniewski, K. 1990: Alpha 1 and alpha 2-adrenergic receptor blockade influences angiotensin Ii facilitation of avoidance behavior and stereotypy in rats. Psychoneuroendocrinology 15(4): 239-252

Kueppers, F. 1976: Alpha 1 antitrypsin M1: a new common genetically determined variant. American Journal of Human Genetics 28(4): 370-377

Boudík, F. 1976: Alpha 1 antitrypsin and chronic bronchitis. Casopis Lekaru Ceskych 115(11): 320-324

Künzer, W. 1977: Alpha 1 antitrypsin deficiency. Klinische Padiatrie 189(3): 199-205

Allen, M.B.; Ward, A.M.; Perks, W.H. 1986: Alpha 1 antitrypsin deficiency due to MMaltonZ phenotype: case report and family study. Thorax 41(7): 568-570

Glauser, M.P. 1975: Alpha 1 antitrypsin deficiency. Physiopathological consequences. Schweizerische Medizinische Wochenschrift 105(31): 970-972

Schmitt, M.G.; Phillips, R.B.; Matzen, R.N.; Rodey, G. 1975: Alpha 1 antitrypsin deficiency: a study of the relationship between the Pi system and genetic markers. American Journal of Human Genetics 27(3): 315-321

Plaitano, G.; Guardascione, F.; Politi, C. 1979: Alpha 1 antitrypsin in cryptogenetic cirrhosis. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 15(2): 165-169

Ceglecka-Tomaszewska, K.; Gutkowska, J.; Chmielewska, D. 1976: Alpha 1 antitrypsin in pulmonary fibrosis in children. Polski Tygodnik Lekarski 31(7): 261-263

Tawil, N.J.; Houde, M.; Blacher, R.; Esch, F.; Reichardt, L.F.; Turner, D.C.; Carbonetto, S. 1990: Alpha 1 beta 1 integrin heterodimer functions as a dual laminin/collagen receptor in neural cells. Biochemistry 29(27): 6540-6544

Lallier, T.; Bronner-Fraser, M. 1992: Alpha 1 beta 1 integrin on neural crest cells recognizes some laminin substrata in a Ca(2+)-independent manner. Journal of Cell Biology 119(5): 1335-1345

Itskovitz, H.D. 1991: Alpha 1 blockers. Safe, effective treatment for hypertension. Postgraduate Medicine 89(8): 89-92 95-8 103-6 Passim

Waite, M.A. 1991: Alpha 1 blockers: antihypertensives whose positive metabolic profile with regard to hyperinsulinaemia and lipid metabolism cannot be ignored. Journal of Internal Medicine. Suppl 735: 113-117

Thornton, J.E.; Goy, R.W.; McEwen, B.S.; Feder, H.H. 1989: Alpha 1 noradrenergic antagonism decreases hormonally-induced and hormonally-independent lordosis. Pharmacology Biochemistry and Behavior 32(2): 421-424

Brisac, A.M. 1990: Alpha 1 receptors and blood pressure control. Mechanisms of hypotensive action of urapidil?. Therapie 45 Suppl. 2: 187-190

Xiong, Z.L.; Sun, Z. 1987: Alpha 1, alpha 2 adrenoceptors: localization and subtypes at pre- or postsynaptic sites. Sheng Li Ke Xue Jin Zhan 18(4): 338-342

Gómez, B.; Borbujo, J.; García-Villalón, A.L.; Nava-Hernández, E.; Valle, J.; García, J.L.; Diéguez, G. 1991: Alpha 1- and alpha 2-adrenergic response in human isolated skin arteries during cooling. General Pharmacology 22(2): 341-346

Skoglund, G.; Lundquist, I.; Ahrén, B. 1987: Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse. European Journal of Pharmacology 143(1): 83-88

White, R.E.; Carrier, G.O. 1986: Alpha 1- and alpha 2-adrenoceptor agonist-induced contraction in rat mesenteric artery upon removal of endothelium. European Journal of Pharmacology 122(3): 349-352

Jie, K.; van Brummelen, P.; Vermey, P.; Timmermans, P.B.; van Zwieten, P.A. 1985: Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm: differences between normotensive and hypertensive subjects. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S89-S91

Appleton, C.P.; Lee, R.W.; Martin, G.V.; Olajos, M.; Goldman, S. 1986: Alpha 1- and alpha 2-adrenoceptor stimulation: changes in venous capacitance in intact dogs. American Journal of Physiology 250(6 Part 2): H1071-H1078

Lew, M.J.; Angus, J.A. 1985: Alpha 1- and alpha 2-adrenoceptor-mediated pressor responses: are they differentiated by calcium antagonists or by functional antagonism?. Journal of Cardiovascular Pharmacology 7(2): 401-408

Guimarães, S.; Moura, D.; Nunes, J.P.; Vaz-da-Silva, M.J.; Guimarães, J.T. 1991: Alpha 1- and alpha 2-adrenoceptors at different levels of the canine saphenous vein. Journal of Neural Transmission. Supplementum 34: 163-169

Yablonsky, F.; Riffaud, J.P.; Lacolle, J.Y.; Dausse, J.P. 1986: Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. European Journal of Pharmacology 121(1): 1-8

Dickinson, S.L.; Gadie, B.; Tulloch, I.F. 1988: Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Psychopharmacology 96(4): 521-527

Bond, R.F.; Johnson, G. 1985: Alpha 1- and alpha 2-adrenoreceptor relationships in SHRs during hypotension. Circulatory Shock 17(2): 109-119

Johnson, A.E.; Nock, B.; McEwen, B.S.; Feder, H.H. 1988: Alpha 1- and alpha 2-noradrenergic receptor binding in guinea pig brain: sex differences and effects of ovarian steroids. Brain Research 442(2): 205-213

Johnson, A.E.; Nock, B.; McEwen, B.S.; Feder, H.H. 1988: Alpha 1- and alpha 2-noradrenergic receptors in steroid-sensitive brain areas: development and response to estradiol-17 beta benzoate in neonatal guinea pigs. Brain Research 470(2): 247-252

Raasmaja, A.; Larsen, P.R. 1989: Alpha 1- and beta-adrenergic agents cause synergistic stimulation of the iodothyronine deiodinase in rat brown adipocytes. Endocrinology 125(5): 2502-2509

Boutjdir, M.; Restivo, M.; Wei, Y.; el-Sherif, N. 1992: Alpha 1- and beta-adrenergic interactions on L-type calcium current in cardiac myocytes. Pflugers Archiv: European Journal of Physiology 421(4): 397-399

Raasmaja, A.; York, D.A. 1988: Alpha 1- and beta-adrenergic receptors in brown adipose tissue of lean (Fa/?) and obese (fa/fa) Zucker rats. Effects of cold-acclimation, sucrose feeding and adrenalectomy. Biochemical Journal 249(3): 831-838

Wilcke, M.; Nedergaard, J. 1989: Alpha 1- and beta-adrenergic regulation of intracellular Ca2+ levels in brown adipocytes. Biochemical and Biophysical Research Communications 163(1): 292-300

Söderpalm, B.; Engel, J.A. 1990: Alpha 1- and beta-adrenoceptor stimulation potentiate the anticonflict effect of a benzodiazepine. Journal of Neural Transmission. General Section 79(3): 155-167

Joziasse, D.H.; Shaper, N.L.; Salyer, L.S.; Van den Eijnden, D.H.; van der Spoel, A.C.; Shaper, J.H. 1990: Alpha 1----3-galactosyltransferase: the use of recombinant enzyme for the synthesis of alpha-galactosylated glycoconjugates. European Journal of Biochemistry 191(1): 75-83

Kishore, N.; Gupta, M.C. 1979: Alpha 1--antitrypsin enzyme deficiency associated with duodenal ulcer--report of a family. Indian Journal of Medical Sciences 33(12): 318-320

Staudacher, E.; Altmann, F.; März, L.; Hård, K.; Kamerling, J.P.; Vliegenthart, J.F. 1992: Alpha 1-6(alpha 1-3)-difucosylation of the asparagine-bound N-acetylglucosamine in honeybee venom phospholipase A2. Glycoconjugate Journal 9(2): 82-85

Horowitz, I.D.; Schulman, E.S. 1989: Alpha 1-Pi for emphysema due to alpha 1-antitrypsin deficiency. American Family Physician 40(3): 223-228

Mogensen, O.; Mogensen, B.; Jakobsen, A. 1989: Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125. Cancer 64(9): 1867-1871

Arnaud, P.; Miribel, L.; Roux, A.F. 1988: Alpha 1-acid glycoprotein. Methods in Enzymology 163: 418-430

Dirienzo, W.; Stefanini, G.F.; Miribel, L.; Paulling, E.E.; Canonica, G.W.; Fudenberg, H.H. 1987: Alpha 1-acid glycoprotein (alpha 1-AGP) on the membrane of human lymphocytes: possible involvement in cellular activation. Immunology Letters 15(2): 167-170

Silamut, K.; Molunto, P.; Ho, M.; Davis, T.M.; White, N.J. 1991: Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. British Journal of Clinical Pharmacology 32(3): 311-315

Ozeki, T.; Imanishi, K.; Uchiyama, T.; Sanefuji, H.; Fujiwara, H.; Mizuno, S.; Tanaka, N.; Suzuki, I. 1988: Alpha 1-acid glycoprotein and hepatic fibrosis. British Journal of Experimental Pathology 69(4): 589-595

Belpaire, F.M.; De Rick, A.; Dello, C.; Fraeyman, N.; Bogaert, M.G. 1987: Alpha 1-acid glycoprotein and serum binding of drugs in healthy and diseased dogs. Journal of Veterinary Pharmacology and Therapeutics 10(1): 43-48

Burrows, F.A.; Lerman, J.; LeDez, K.M.; Strong, H.A. 1990: Alpha 1-acid glycoprotein and the binding of lidocaine in children with congenital heart disease. Canadian Journal of Anaesthesia 37(8): 883-888

Fraeyman, N.F.; Dello, C.D.; Belpaire, F.M. 1988: Alpha 1-acid glycoprotein concentration and molecular heterogeneity: relationship to oxprenolol binding in serum from healthy volunteers and patients with lung carcinoma or cirrhosis. British Journal of Clinical Pharmacology 25(6): 733-740

Contin, M.; Riva, R.; Albani, F.; Perucca, E.; Lamontanara, G.; Baruzzi, A. 1985: Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy. European Journal of Clinical Pharmacology 29(2): 211-214

Beilby, J.P.; O'Leary, B.A. 1990: Alpha 1-acid glycoprotein decreases recovery of total protein in urine when trichloroacetic acid is used to precipitate the proteins. Clinical Chemistry 36(3): 565-567

Neitchev, V.Z. 1989: Alpha 1-acid glycoprotein effects on the permeability changes in reconstituted membranes. Progress in Clinical and Biological Research 300: 243-246

Jewell, R.C.; Brouwer, K.L.; McNamara, P.J. 1989: Alpha 1-acid glycoprotein high-performance liquid chromatography column (EnantioPAC) as a screening tool for protein binding. Journal of Chromatography 487(2): 257-264

Rapp, W.; Heim, M.; von Mikulicz-Radecki, J.G.; Ludwig, R. 1975: Alpha 1-acid glycoprotein in gastric cancer juice. Klinische Wochenschrift 53(3): 139-141

Boutten, A.; Dehoux, M.; Deschenes, M.; Rouzeau, J.D.; Bories, P.N.; Durand, G. 1992: Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. European Journal of Immunology 22(10): 2687-2695

Liu, H.M.; Brossmer, R.; Schmid, K. 1989: Alpha 1-acid glycoprotein promotes nerve growth in vitro. Progress in Clinical and Biological Research 300: 239-242

Nånberg, E.; Putney, J. 1986: Alpha 1-adrenergic activation of brown adipocytes leads to an increased formation of inositol polyphosphates. Febs Letters 195(1-2): 319-322

Kow, L.M.; Weesner, G.D.; Pfaff, D.W. 1992: Alpha 1-adrenergic agonists act on the ventromedial hypothalamus to cause neuronal excitation and lordosis facilitation: electrophysiological and behavioral evidence. Brain Research 588(2): 237-245

Apkon, M.; Nerbonne, J.M. 1988: Alpha 1-adrenergic agonists selectively suppress voltage-dependent K+ current in rat ventricular myocytes. Proceedings of the National Academy of Sciences of the United States of America 85(22): 8756-8760

Brown, R.D.; Prendiville, P.; Cain, C. 1986: Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness. Molecular Pharmacology 29(6): 531-539

Hodges, R.R.; Dicker, D.M.; Rose, P.E.; Dartt, D.A. 1992: Alpha 1-adrenergic and cholinergic agonists use separate signal transduction pathways in lacrimal gland. American Journal of Physiology 262(6 Part 1): G1087-G1096

Brown, J.H.; Buxton, I.L.; Brunton, L.L. 1985: Alpha 1-adrenergic and muscarinic cholinergic stimulation of phosphoinositide hydrolysis in adult rat cardiomyocytes. Circulation Research 57(4): 532-537

Kowatch, M.A.; Roth, G.S. 1991: Alpha 1-adrenergic and muscarinic-cholinergic stimulated inositol trisphosphate production may proceed through different post-receptor signal transduction pathways in parotid acini. Biochemical and Biophysical Research Communications 176(3): 1291-1297

Beretta-Piccoli, C.; Ferrier, C.; Weidmann, P. 1986: Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension. Hypertension 8(5): 407-414

Kenney, W.L.; Tankersley, C.G.; Newswanger, D.L.; Puhl, S.M. 1991: Alpha 1-adrenergic blockade does not alter control of skin blood flow during exercise. American Journal of Physiology 260(3 Part 2): H855-H861

Liang, I.Y.; Jones, C.E. 1985: Alpha 1-adrenergic blockade increases coronary blood flow during coronary hypoperfusion. American Journal of Physiology 249(6 Part 2): H1070-H1077

Maze, M.; Hayward, E.; Gaba, D.M. 1985: Alpha 1-adrenergic blockade raises epinephrine-arrhythmia threshold in halothane-anesthetized dogs in a dose-dependent fashion. Anesthesiology 63(6): 611-615

Miller, C.A. 1992: Alpha 1-adrenergic blockers. Geriatric Nursing 13(1): 55

Gwirtz, P.A.; Overn, S.P.; Mass, H.J.; Jones, C.E. 1986: Alpha 1-adrenergic constriction limits coronary flow and cardiac function in running dogs. American Journal of Physiology 250(6 Part 2): H1117-H1126

Edwards, S.J.; Rattigan, S.; Colquhoun, E.Q.; Lockwood, S.C.; Woodcock, E.A.; Clark, M.G. 1989: Alpha 1-adrenergic control of contractility and coronary flow in the perfused rat heart. American Journal of Physiology 256(2 Part 2): H334-H340

Jones, C.E.; Gwirtz, P.A. 1990: Alpha 1-adrenergic coronary constriction during exercise and ischemia. Basic Research in Cardiology 85(Suppl 1): 177-192

Cruise, J.L.; Knechtle, S.J.; Bollinger, R.R.; Kuhn, C.; Michalopoulos, G. 1987: Alpha 1-adrenergic effects and liver regeneration. Hepatology 7(6): 1189-1194

Terzic, A.; Pucéat, M.; Clément, O.; Scamps, F.; Vassort, G. 1992: Alpha 1-adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells. Journal of Physiology 447: 275-292

Nånberg, E.; Nedergaard, J. 1987: Alpha 1-adrenergic inositol trisphosphate production in brown adipocytes is Na+ dependent. Biochimica et Biophysica Acta 930(3): 438-445

Takayanagi, I.; Onozuka, S. 1990: Alpha 1-adrenergic partial agonists utilize cytosolic Ca2+ more effectively for contraction in aortic smooth muscle. Canadian Journal of Physiology and Pharmacology 68(10): 1329-1333

Chik, C.L.; Ho, A.K.; Klein, D.C. 1988: Alpha 1-adrenergic potentiation of vasoactive intestinal peptide stimulation of rat pinealocyte adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate: evidence for a role of calcium and protein kinase-C. Endocrinology 122(2): 702-708

Randle, J.C.; Bourque, C.W.; Renaud, L.P. 1986: Alpha 1-adrenergic receptor activation depolarizes rat supraoptic neurosecretory neurons in vitro. American Journal of Physiology 251(3 Part 2): R569-R574

Randle, J.C.; Mazurek, M.; Kneifel, D.; Dufresne, J.; Renaud, L.P. 1986: Alpha 1-adrenergic receptor activation releases vasopressin and oxytocin from perfused rat hypothalamic explants. Neuroscience Letters 65(2): 219-223

O'Neill, C.; Fowler, C.J.; Winblad, B. 1989: Alpha 1-adrenergic receptor binding sites in post-mortal human cerebral microvessel preparations: preservation in multi-infarct dementia and dementia of Alzheimer type. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1(4): 303-310

Uchino, K.; Nishikimi, T.; Frohlich, E.D. 1991: Alpha 1-adrenergic receptor blockade reduces afferent and efferent glomerular arteriolar resistances in SHR. American Journal of Physiology 261(3 Part 2): R576-R580

Drouva, S.V.; Faivre-Bauman, A.; Loudes, C.; Laplante, E.; Kordon, C. 1991: Alpha 1-adrenergic receptor coupling with phospholipase-C is negatively regulated by protein kinase-C in primary cultures of hypothalamic neurons and glial cells. Endocrinology 129(3): 1605-1613

Rangaraj, N.; Kalant, H.; Beaugé, F. 1985: Alpha 1-adrenergic receptor involvement in norepinephrine-ethanol inhibition of rat brain Na+ -K+ ATPase and in ethanol tolerance. Canadian Journal of Physiology and Pharmacology 63(9): 1075-1079

Izzo, N.J.; Seidman, C.E.; Collins, S.; Colucci, W.S. 1990: Alpha 1-adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells. Proceedings of the National Academy of Sciences of the United States of America 87(16): 6268-6271

Kanterman, R.Y.; Felder, C.C.; Brenneman, D.E.; Ma, A.L.; Fitzgerald, S.; Axelrod, J. 1990: Alpha 1-adrenergic receptor mediates arachidonic acid release in spinal cord neurons independent of inositol phospholipid turnover. Journal of Neurochemistry 54(4): 1225-1232

Sawutz, D.G.; Sena, L.M.; Cornett, L.E.; Graham, R.M. 1987: Alpha 1-adrenergic receptor photoaffinity labeling in intact cells. Biochemical Pharmacology 36(22): 4027-4032

Crews, F.T.; Raulli, R.; Gonzales, R.; Sumners, C.; Raizada, M. 1988: Alpha 1-adrenergic receptor stimulated responses. Journal of Cardiovascular Pharmacology 11(Suppl 1): S99-106

Long, C.S.; Ordahl, C.P.; Simpson, P.C. 1989: Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. Journal of Clinical Investigation 83(3): 1078-1082

Han, C.D.; Wilson, K.M.; Minneman, K.P. 1990: Alpha 1-adrenergic receptor subtypes and formation of inositol phosphates in dispersed hepatocytes and renal cells. Molecular Pharmacology 37(6): 903-910

Minneman, K.P. 1988: Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacological Reviews 40(2): 87-119

Terman, B.I.; Slivka, S.R.; Hughes, R.J.; Insel, P.A. 1987: Alpha 1-adrenergic receptor-linked guanine nucleotide-binding protein in muscle and kidney epithelial cells. Molecular Pharmacology 31(1): 12-20

Llahi, S.; Fain, J.N. 1992: Alpha 1-adrenergic receptor-mediated activation of phospholipase D in rat cerebral cortex. Journal of Biological Chemistry 267(6): 3679-3685

Sumners, C.; Watkins, L.L.; Raizada, M.K. 1986: Alpha 1-adrenergic receptor-mediated downregulation of angiotensin Ii receptors in neuronal cultures. Journal of Neurochemistry 47(4): 1117-1126

Yoshimura, N.; Sasa, M.; Yoshida, O.; Takaori, S. 1990: Alpha 1-adrenergic receptor-mediated excitation from the locus coeruleus of the sacral parasympathetic preganglionic neuron. Life Sciences 47(9): 789-797

Johnson, R.D.; Minneman, K.P. 1985: Alpha 1-adrenergic receptors and stimulation of [3H]inositol metabolism in rat brain: regional distribution and parallel inactivation. Brain Research 341(1): 7-15

Cruise, J.L. 1991: Alpha 1-adrenergic receptors in liver regeneration. Digestive Diseases and Sciences 36(4): 485-488

Feldstein, J.B.; Pacitti, A.J.; Sumners, C.; Raizada, M.K. 1986: Alpha 1-adrenergic receptors in neuronal cultures from rat brain: increased expression in the spontaneously hypertensive rat. Journal of Neurochemistry 47(4): 1190-1198

Shaul, P.W.; Magness, R.R.; Muntz, K.H.; DeBeltz, D.; Buja, L.M. 1990: Alpha 1-adrenergic receptors in pulmonary and systemic vascular smooth muscle. Alterations with development and pregnancy. Circulation Research 67(5): 1193-1200

Buchthal, S.D.; Bilezikian, J.P.; Danilo, P. 1987: Alpha 1-adrenergic receptors in the adult, neonatal, and fetal canine heart. Developmental Pharmacology and Therapeutics 10(2): 90-99

Puig, J.F.; Pacitti, A.J.; Guzman, N.J.; Crews, F.T.; Sumners, C.; Raizada, M.K. 1990: Alpha 1-adrenergic receptors in the brain: characterization in astrocytic glial cultures and comparison with neuronal cultures. Brain Research 527(2): 318-325

Kondratenko, T.I.; Kuzina, N.V.; Zakharova, I.V.; Leont'ev, A.F.; Pashkevich, D.D.; Seniakovich, V.M.; Aleksandrov, A.E.; Klochkov, S.A. 1992: Alpha 1-adrenergic receptors in the liver parenchyma of children: the changes in cirrhosis. Biulleten' Eksperimental'noi Biologii i Meditsiny 114(8): 134-135

De Souza, E.B.; Kuyatt, B.L. 1987: Alpha 1-adrenergic receptors in the neural lobe of the rat pituitary: autoradiographic identification and localization. Endocrinology 120(6): 2227-2233

Ambudkar, I.S.; Melvin, J.E.; Baum, B.J. 1988: Alpha 1-adrenergic regulation of Cl- and Ca2+ movements in rat parotid acinar cells. Pflugers Archiv: European Journal of Physiology 412(1-2): 75-79

Berman, M.I.; Jerdack, G.; Thomas, C.G.; Nayfeh, S.N. 1987: Alpha 1-adrenergic regulation of TSH-stimulated cyclic AMP accumulation in rat thyroid cells. Archives of Biochemistry and Biophysics 253(1): 249-256

Nomura, T.; Nomura, Y.; Tachibana, M.; Nomura, H.; Ukai, K.; Yokoyama, R.; Hagino, Y. 1991: Alpha 1-adrenergic regulation of ketogenesis in isolated rat hepatocytes. Biochimica et Biophysica Acta 1092(1): 94-100

Oda, Y.; Tajima, K.; Mori-Tanaka, M.; Matsui, I.; Kitajima, K.; Miyagawa, J.; Hanafusa, T.; Mashita, K.; Tarui, S. 1991: Alpha 1-adrenergic regulation of thyrotropin-stimulated release of 3, 5, 3' -triiodothyronine and thyroxine from perifused mouse thyroid. Journal of Endocrinological Investigation 14(10): 867-873

Baum, B.J.; Kuyatt, B.L.; Helman, Y.; Gee, M.V.; Roth, G.S. 1985: Alpha 1-adrenergic responsiveness of young adult and aged rat submandibular cells in vitro. Comparative Biochemistry and Physiology. C Comparative Pharmacology and Toxicology 81(1): 121-124

Liedtke, C.M. 1992: Alpha 1-adrenergic signaling in human airway epithelial cells involves inositol lipid and phosphate metabolism. American Journal of Physiology 262(2 Part 1): L183-L191

Nakaki, T.; Nakayama, M.; Yamamoto, S.; Kato, R. 1990: Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Molecular Pharmacology 37(1): 30-36

Goligorsky, M.S.; Hruska, K.A.; Loftus, D.J.; Elson, E.L. 1986: Alpha 1-adrenergic stimulation and cytoplasmic free calcium concentration in cultured renal proximal tubular cells: evidence for compartmentalization of quin-2 and fura-2. Journal of Cellular Physiology 128(3): 466-474

Jakob, A.; Becker, J.; Schöttli, G.; Fritzsch, G. 1989: Alpha 1-adrenergic stimulation causes Mg2+ release from perfused rat liver. Febs Letters 246(1-2): 127-130

Li, K.; Rouleau, J.L. 1991: Alpha 1-adrenergic stimulation increases the Vmax of isolated myocardial papillary muscles. Canadian Journal of Physiology and Pharmacology 69(12): 1804-1809

Ikeda, U.; Tsuruya, Y.; Yaginuma, T. 1991: Alpha 1-adrenergic stimulation is coupled to cardiac myocyte hypertrophy. American Journal of Physiology 260(3 Part 2): H953-H956

Dasso, L.; Connolly, E.; Nedergaard, J. 1990: Alpha 1-adrenergic stimulation of Cl- efflux in isolated brown adipocytes. Febs Letters 262(1): 25-28

Wallert, M.A.; Fröhlich, O. 1992: Alpha 1-adrenergic stimulation of Na-H exchange in cardiac myocytes. American Journal of Physiology 263(5 Part 1): C1096-C1102

Burch, R.M.; Luini, A.; Mais, D.E.; Corda, D.; Vanderhoek, J.Y.; Kohn, L.D.; Axelrod, J. 1986: Alpha 1-adrenergic stimulation of arachidonic acid release and metabolism in a rat thyroid cell line. Mediation of cell replication by prostaglandin E2. Journal of Biological Chemistry 261(24): 11236-11241

Pandiella, A.; Elahi, F.R.; Vallar, L.; Spada, A. 1988: Alpha 1-adrenergic stimulation of in vitro growth hormone release and cytosolic free Ca2+ in rat somatotrophs. Endocrinology 122(4): 1419-1425

Borst, S.E.; Scarpace, P.J. 1990: Alpha 1-adrenergic stimulation of inositide hydrolysis in liver of senescent rats. Mechanisms of Ageing and Development 56(3): 275-280

Muraki, T.; Tsukahara, F.; Fujii, E.; Nomoto, T. 1991: Alpha 1-adrenergic stimulation of iodide organification in mouse thyroid--inhibition by protein kinase C inhibitors. Archives Internationales de Pharmacodynamie et de Therapie 314: 122-132

Stark, B.; Keller, U. 1987: Alpha 1-adrenergic stimulation of ketogenesis and fatty acid oxidation is associated with inhibition of lipogenesis in rat hepatocytes. Experientia 43(10): 1104-1106

Villalobos-Molina, R.; Joseph, J.A.; Roth, G.S. 1992: Alpha 1-adrenergic stimulation of low Km GTPase in rat striata is diminished with age. Brain Research 590(1-2): 303-304

Majesky, M.W.; Daemen, M.J.; Schwartz, S.M. 1990: Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. Journal of Biological Chemistry 265(2): 1082-1088

Meidell, R.S.; Sen, A.; Henderson, S.A.; Slahetka, M.F.; Chien, K.R. 1986: Alpha 1-adrenergic stimulation of rat myocardial cells increases protein synthesis. American Journal of Physiology 251(5 Part 2): H1076-H1084

Baines, A.D.; Drangova, R.; Ho, P. 1987: Alpha 1-adrenergic stimulation of renal Na reabsorption requires glucose metabolism. American Journal of Physiology 253(5 Part 2): F810-F815

Kurz, T.; Yamada, K.A.; DaTorre, S.D.; Corr, P.B. 1991: Alpha 1-adrenergic system and arrhythmias in ischaemic heart disease. European Heart Journal 12 Suppl F: 88-98

Scott, J.S.; Garon, H.; Broadstone, R.V.; Derksen, F.J.; Robinson, N.E. 1988: Alpha 1-adrenergic-induced airway obstruction in ponies with recurrent pulmonary disease. Journal of Applied Physiology 65(2): 687-692

Sugden, L.A.; Sugden, D.; Klein, D.C. 1987: Alpha 1-adrenoceptor activation elevates cytosolic calcium in rat pinealocytes by increasing net influx. Journal of Biological Chemistry 262(2): 741-745

Forster, C.; Carter, S.L.; Armstrong, P.W. 1989: Alpha 1-adrenoceptor activity in arterial smooth muscle following congestive heart failure. Canadian Journal of Physiology and Pharmacology 67(2): 110-115

Kitakaze, M.; Hori, M.; Tamai, J.; Iwakura, K.; Koretsune, Y.; Kagiya, T.; Iwai, K.; Kitabatake, A.; Inoue, M.; Kamada, T. 1987: Alpha 1-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circulation Research 60(5): 631-639

Azuma, H.; Sugimoto-Tokushima, M.; Tanaka, K.; Ikenoue, Y.; Ito, S.; Ishikawa, M. 1989: Alpha 1-adrenoceptor antagonist activity of novel pyrimidine derivatives (SHI437 and IK29) in rabbit aorta and trigone of the bladder. British Journal of Pharmacology 96(4): 1000-1006

Petitti, N.; Etgen, A.M. 1990: Alpha 1-adrenoceptor augmentation of beta-stimulated cAMP formation is enhanced by estrogen and reduced by progesterone in rat hypothalamic slices. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 10(8): 2842-2849

Smyth, D.D.; Umemura, S.; Pettinger, W.A. 1986: Alpha 1-adrenoceptor blockade and altered renal alpha 2-adrenoceptors: a model(?) for the study of genetically altered alpha 2-adrenoceptors in hypertensive rats. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(3): S205-S208

Grohs, J.G.; Fischer, G.; Huber, S.; Raberger, G. 1991: Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs. Journal of Autonomic Pharmacology 11(2): 101-107

Shiraishi, K.; Moriya, M.; Miyake, N.; Takayanagi, I. 1992: Alpha 1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta--do they distinguish between subtypes?. General Pharmacology 23(5): 843-845

Terrón, J.A.; Ransanz, V.; Ibarra, M.; Hong, E.; Villalón, C.M. 1992: Alpha 1-adrenoceptor blocking properties of spiroxatrine in rat aorta. Life Sciences 51(1): PL1-PL6

Hamilton, C.A.; Reid, J.L. 1988: Alpha 1-adrenoceptor desensitisation. European Journal of Pharmacology 152(1-2): 179-183

Spina, D.; Rigby, P.J.; Paterson, J.W.; Goldie, R.G. 1989: Alpha 1-adrenoceptor function and autoradiographic distribution in human asthmatic lung. British Journal of Pharmacology 97(3): 701-708

Fowler, C.J.; Fagervall, I.; Minor, B.G.; Ross, S.B. 1986: Alpha 1-adrenoceptor function in the rat hippocampus as assessed by noradrenaline-stimulated inositol phospholipid breakdown after destruction of noradrenergic neurons by neonatal 6-hydroxydopamine treatment. Journal of Pharmacy and Pharmacology 38(5): 385-388

Osborn, J.L.; Harland, R.W. 1988: Alpha 1-adrenoceptor mediation of urinary bicarbonate excretion. American Journal of Physiology 255(6 Part 2): F1116-F1121

Muraki, T.; Nakaki, T.; Kato, R. 1987: Alpha 1-adrenoceptor production of inositol phosphates mediates the inhibition of thyroxine release from the mouse thyroid. Journal of Endocrinology 115(2): 289-293

Meretyk, S.; Tang, R.; Shapiro, E.; Kyncl, J.J.; Lepor, H. 1992: Alpha 1-adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brain. Prostate 20(2): 159-165

Boutjdir, M.; el-Sherif, N. 1991: Alpha 1-adrenoceptor regulation of delayed afterdepolarizations and triggered activity in subendocardial Purkinje fibers surviving 1 day of myocardial infarction. Journal of Molecular and Cellular Cardiology 23(1): 83-90

Holck, M.I. 1988: Alpha 1-adrenoceptor reserve and effects of a Ca2+ entry blocker (Ro 18-3981) on aorta of spontaneously hypertensive rats. European Journal of Pharmacology 148(1): 9-15

Elliott, H.L. 1988: Alpha 1-adrenoceptor responsiveness: the influence of age. Journal of Cardiovascular Pharmacology 12(Suppl 8): S116-S123

Tohse, N.; Nakaya, H.; Kanno, M. 1992: Alpha 1-adrenoceptor stimulation enhances the delayed rectifier K+ current of guinea pig ventricular cells through the activation of protein kinase C. Circulation Research 71(6): 1441-1446

Iwakura, K.; Hori, M.; Watanabe, Y.; Kitabatake, A.; Cragoe, E.J.; Yoshida, H.; Kamada, T. 1990: Alpha 1-adrenoceptor stimulation increases intracellular pH and Ca2+ in cardiomyocytes through Na+/H+ and Na+/Ca2+ exchange. European Journal of Pharmacology 186(1): 29-40

Molderings, G.J.; Schümann, H.J. 1989: Alpha 1-adrenoceptor stimulation reduced the positive chronotropic effect of simultaneously administered beta-adrenoceptor- and H2-receptor agonists in guinea-pig right atria. Archives Internationales de Pharmacodynamie et de Therapie 297: 18-28

Oriowo, M.A.; Bevan, J.A. 1986: Alpha 1-adrenoceptor subtype mediates norepinephrine-induced contraction of the rabbit isolated ovarian artery. Journal of Cardiovascular Pharmacology 8(4): 858-863

Piascik, M.T.; Kusiak, J.W.; Barron, K.W. 1990: Alpha 1-adrenoceptor subtypes and the regulation of peripheral hemodynamics in the conscious rat. European Journal of Pharmacology 186(2-3): 273-278

Torres-Márquez, M.E.; Villalobos-Molina, R.; García-Sáinz, J.A. 1991: Alpha 1-adrenoceptor subtypes in aorta (alpha 1A) and liver (alpha 1B). European Journal of Pharmacology 206(3): 199-202

Maruyama, K.; Tsuchihashi, H.; Baba, S.; Mano, F.; Nagatomo, T. 1992: Alpha 1-adrenoceptor subtypes in bovine prostate. Journal of Pharmacy and Pharmacology 44(9): 727-730

Oshita, M.; Takita, M.; Kigoshi, S.; Muramatsu, I. 1992: Alpha 1-adrenoceptor subtypes in rabbit thoracic aorta. Japanese Journal of Pharmacology 58(Suppl): 276p

Kinami, J.; Tsuchihashi, H.; Baba, S.; Mano, F.; Maruyama, K.; Nagatomo, T. 1992: Alpha 1-adrenoceptor subtypes in the rat ventricular muscle. Journal of Pharmacy and Pharmacology 44(2): 97-100

Schwietert, H.R.; Mathy, M.J.; Wilhelm, D.; Wilffert, B.; Pfaffendorf, M.; van Zwieten, P.A. 1992: Alpha 1-adrenoceptor-mediated Ca(2+)-entry from the extracellular fluid and Ca(2+)-release from intracellular stores: no role for alpha 1A,B-adrenoceptor subtypes in the pithed rat. Journal of Autonomic Pharmacology 12(3): 125-136

Wilson, C.; Cooper, S.M.; Buckingham, R.E.; Clapham, J.C. 1987: Alpha 1-adrenoceptor-mediated contraction of rabbit mesenteric artery: a role for intra- and extracellular calcium pools. Journal of Cardiovascular Pharmacology 9(4): 401-406

Kendall, D.A.; Brown, E.; Nahorski, S.R. 1985: Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation. European Journal of Pharmacology 114(1): 41-52

Otani, H.; Otani, H.; Das, D.K. 1988: Alpha 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic response in rat left ventricular papillary muscles. Circulation Research 62(1): 8-17

Xiang, H.; McNeill, J.H. 1991: Alpha 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts. American Journal of Physiology 260(2 Part 2): H557-H562

Bhalla, R.C.; Aqel, M.B.; Sharma, R.V. 1986: Alpha 1-adrenoceptor-mediated responses in the vascular smooth muscle of spontaneously hypertensive rats. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(3): S65-S67

Rugevics, C.U.; Schümann, H.J. 1987: Alpha 1-adrenoceptors in guinea-pig heart ventricles. [3H]prazosin and [125I]IBE 2254 are bound specifically to a receptor population with high affinity and low density. Archives Internationales de Pharmacodynamie et de Therapie 289(2): 234-250

Walkenbach, R.J.; Ye, G.S.; Reinach, P.S.; Boney, F. 1991: Alpha 1-adrenoceptors in human corneal epithelium. Investigative Ophthalmology and Visual Science 32(12): 3067-3072

Villalobos-Molina, R.; Miyamoto, A.; Kowatch, M.A.; Roth, G.S. 1992: Alpha 1-adrenoceptors in parotid cells: age does not alter the ratio of alpha 1A and alpha 1B subtypes. European Journal of Pharmacology 226(2): 129-131

Guan, Y.Y.; Chen, K.M.; Sun, J.J. 1991: Alpha 1-adrenoceptors mediate the responses to BHT-920 and rauwolscine in dog mesenteric artery after partial depolarization by KCl. European Journal of Pharmacology 200(2-3): 283-287

Gross, G.; Hanft, G.; Rugevics, C.U. 1988: Alpha 1-adrenoceptors of rat myocardium: comparison of agonist binding and positive inotropic response. Naunyn-Schmiedeberg's Archives of Pharmacology 338(5): 582-588

Fedida, D.; Braun, A.P.; Giles, W.R. 1991: Alpha 1-adrenoceptors reduce background K+ current in rabbit ventricular myocytes. Journal of Physiology 441: 673-684

Hanft, G.; Gross, G.; Beckeringh, J.J.; Korstanje, C. 1989: Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites. Journal of Pharmacy and Pharmacology 41(10): 714-716

Pool, J.L.; Lenz, M.L.; Taylor, A.A. 1990: Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations. Journal of Human Hypertension 4(Suppl 3): 23-33

Kaye, B.; Cussans, N.J.; Faulkner, J.K.; Stopher, D.A.; Reid, J.L. 1986: The metabolism and kinetics of doxazosin in man, mouse, rat and dog. British Journal of Clinical Pharmacology 21(Suppl 1): 19s-25s

Van Kleef, E.M.; Smits, J.F.; De Mey, J.G.; Cleutjens, J.P.; Lombardi, D.M.; Schwartz, S.M.; Daemen, M.J. 1992: Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circulation Research 70(6): 1122-1127

Tanganelli, S.; Antonelli, T.; Simonato, M.; Spalluto, G.; Tomasini, C.; Bianchi, C.; Beani, L. 1989: Alpha 1-adrenoreceptor-mediated increase in acetylcholine release in brain slices during morphine tolerance. Journal of Neurochemistry 53(4): 1072-1076

Dieguez, C.; Foord, S.M.; Peters, J.R.; Hall, R.; Scanlon, M.F. 1985: Alpha 1-adrenoreceptors and alpha 1-adrenoreceptor-mediated thyrotropin release in cultures of euthyroid and hypothyroid rat anterior pituitary cells. Endocrinology 117(2): 624-630

Jie, K.; van Brummelen, P.; Vermey, P.; Timmermans, P.B.; van Zwieten, P.A. 1986: Alpha 1-and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. Journal of Cardiovascular Pharmacology 8(1): 190-196

Haynes, J.; Pennefather, J.N. 1988: Alpha 1-and alpha 2-adrenoceptors of the circular myometrium from the dioestrous guinea-pig. Clinical and Experimental Pharmacology and Physiology 15(9): 695-701

Kaiser, D.; Rennert, O.M.; Joller-Jemelka, H.; Götze, H.; Sollberger, H.; Kehrli, P. 1975: Alpha 1-anti trypsin-deficiency: combination of pulmonary emphysema and liver cirrhosis in infancy. Klinische Wochenschrift 53(3): 117-124

Matsubara, E.; Hirai, S.; Amari, M.; Shoji, M.; Yamaguchi, H.; Okamoto, K.; Ishiguro, K.; Harigaya, Y.; Wakabayashi, K. 1990: Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Annals of Neurology 28(4): 561-567

Kanai, H.; Tanaka, M.; Hirai, S. 1991: Alpha 1-antichymotrypsin has a trophic effect on hippocampal neurons in vitro. Neuroscience Letters 125(2): 163-165

Abraham, C.R.; Potter, H. 1989: Alpha 1-antichymotrypsin in brain aging and disease. Progress in Clinical and Biological Research 317: 1037-1048

Abraham, C.R.; Shirahama, T.; Potter, H. 1990: Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiology of Aging 11(2): 123-129

Shoji, M.; Hirai, S.; Yamaguchi, H.; Harigaya, Y.; Ishiguro, K.; Matsubara, E. 1991: Alpha 1-antichymotrypsin is present in diffuse senile plaques. a comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. American Journal of Pathology 138(1): 247-257

Abraham, C.R.; Selkoe, D.J.; Potter, H.; Price, D.L.; Cork, L.C. 1989: Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits. Neuroscience 32(3): 715-720

Hachulla, E.; Laine, A.; Hayem, A. 1988: Alpha 1-antichymotrypsin microheterogeneity in crossed immunoaffinoelectrophoresis with free concanavalin A: a useful diagnostic tool in inflammatory syndrome. Clinical Chemistry 34(5): 911-915

Arnaud, P.; Chapuis-Cellier, C. 1988: Alpha 1-antitrypsin. Methods in Enzymology 163: 400-418

Antonelli, M.; Castello, M.A.; Borsetto Menghi, A.M. 1976: Alpha 1-antitrypsin (alpha 1-AT) in cystic fibrosis. La Pediatria 84(2): 203-207

Takahashi, H.; Crystal, R.G. 1990: Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons. American Journal of Human Genetics 47(3): 403-413

Janus, E.D. 1988: Alpha 1-antitrypsin Pi types in COPD patients. Chest 94(2): 446-447

Lieberman, J.; Winter, B.; Sastre, A. 1986: Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 89(3): 370-373

Holmes, M.D.; Brantly, M.L.; Fells, G.A.; Crystal, R.G. 1990: Alpha 1-antitrypsin Wbethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variant. Biochemical and Biophysical Research Communications 170(3): 1013-1020

Bednarski, W.; Lewandowska, J.; Pilarek, M.; Piltz, D. 1979: Alpha 1-antitrypsin activity in asthma and asthmatic bronchitis in children treated at a sanatorium at Szczawno spa. Polski Tygodnik Lekarski 34(15): 565-567

Chevance, L.G.; Causse, J.R.; Bergès, J. 1976: Alpha 1-antitrypsin activity of perilymph. Occurrence during progression of otospongiosis. Archives of Otolaryngology 102(6): 363-364

Bruun-Petersen, K.; Bruun-Petersen, G.; Dahl, R.; Larsen, B.; Kølvraa, S.; Koch, J.; Bolund, L.; Gregersen, N. 1992: Alpha 1-antitrypsin alleles in patients with pulmonary emphysema, detected by DNA amplification (PCR) and oligonucleotide probes. European Respiratory Journal 5(5): 531-537

Gollin, P.A.; Kalaria, R.N.; Eikelenboom, P.; Rozemuller, A.; Perry, G. 1992: Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. Neuroreport 3(2): 201-203

Kuryliszyn-Moskal, A.; Bernacka, K.; Sierakowski, S. 1988: Alpha 1-antitrypsin and alpha 1-antichymotrypsin serum level in relation to staging and postoperative clinical course of human colorectal cancer. Advances in Experimental Medicine and Biology 240: 561-564

Seitz, G.; Stemmildt, Y.; Wernert, N.; Strauss, M.; Dhom, G. 1986: Alpha 1-antitrypsin and antichymotrypsin in gastric carcinoma. Verhandlungen der Deutschen Gesellschaft für Pathologie 70: 217-220

Tountas, Y.; Sparos, L.; Theodoropoulos, C.; Trichopoulos, D. 1985: Alpha 1-antitrypsin and cancer of the pancreas. Digestion 31(1): 37-40

Ozeki, T.; Imanishi, K.; Ueda, H.; Uchiyama, T.; Funakoshi, K.; Suzuki, I.; Ohuchi, K.; Kan, M.; Satoh, T. 1989: Alpha 1-antitrypsin and hepatic fibrosis. British Journal of Experimental Pathology 70(2): 143-152

Szmidt, M.; Grzelewska-Rzymowska, I.; Kowalski, M.L.; Rozniecki, J. 1991: Alpha 1-antitrypsin and its phenotype in patients with asthma and aspirin hypersensitivity. Pneumonologia i Alergologia Polska 59(3-4): 114-120

Mansurov, K.K.; Voznesenskiĭ, N.K. 1976: Alpha 1-antitrypsin and its role in development of liver diseases. Klinicheskaia Meditsina 54(11): 19-24

Sergeeva, K.M.; Grinbaum, N.B.; Ivanova, I.N. 1977: Alpha 1-antitrypsin and its significance in children's diseases. Pediatriia 11: 63-66

Gomzi, M.; Stilinovic, L.; Godnic-Cvar, J. 1989: Alpha 1-antitrypsin and lung function in cement workers. La Medicina del Lavoro 80(4): 301-306

Kwan, T.H.; Smoller, B.R.; Schneider, D.R. 1985: Alpha 1-antitrypsin and lysozyme in fibrous papules and angiofibromas. Journal of the American Academy of Dermatology 12(1 Part 1): 99-101

Gupta, A.K.; Sarin, G.S.; Mathur, M.D.; Ghosh, B. 1988: Alpha 1-antitrypsin and serum albumin in tear fluids in acute adenovirus conjunctivitis. British Journal of Ophthalmology 72(5): 390-393

Riley, J.H.; Bathurst, I.C.; Edbrooke, M.R.; Carrell, R.W.; Craig, R.K. 1985: Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver. Febs Letters 189(2): 361-366

Tzonou, A.; Sparos, L.; Kalapothaki, V.; Zavitsanos, X.; Rebelakos, A.; Trichopoulos, D. 1990: Alpha 1-antitrypsin and survival in hepatocellular carcinoma. British Journal of Cancer 61(1): 72-73

Trichopoulos, D.; Tzonou, A.; Kalapothaki, V.; Sparos, L.; Kremastinou, T.; Skoutari, M. 1990: Alpha 1-antitrypsin and survival in pancreatic cancer. International Journal of Cancer 45(4): 685-686

Fischbach, W.; Becker, W. 1985: Alpha 1-antitrypsin and the percentage of fecal excretion of 111In-oxin-labeled leukocytes in Crohn disease. Deutsche Medizinische Wochenschrift 110(31-32): 1233

Schena, M.; Quadri, A.; Ragazzoni, G.; Corti, P. 1985: Alpha 1-antitrypsin as a tumor marker. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 21(1): 87-96

Hundegger, K.; Karbach, U. 1992: Alpha 1-antitrypsin as an endogenous marker for the detection of intestinal protein excretion--problems and controversies in dealing with a new method. Zeitschrift für Gastroenterologie 30(3): 204-206

Kulesza, E.; Lisowska, B.; Tomaszewski, L.; Dobrowolski, W.; Socha, J. 1992: Alpha 1-antitrypsin as an endogenous marker of protein-losing enteropathies. Polski Tygodnik Lekarski 47(3-4): 98-101

Bai, J.C.; Sambuelli, A.; Niveloni, S.; Sugai, E.; Mazure, R.; Kogan, Z.; Pedreira, S.; Boerr, L. 1991: Alpha 1-antitrypsin clearance as an aid in the management of patients with celiac disease. American Journal of Gastroenterology 86(8): 986-991

Hinojosa, J.; Primo, J.; López, A.; Miralles, A. 1991: Alpha 1-antitrypsin clearance values as an early predictor of relapse in Crohn's disease. American Journal of Gastroenterology 86(5): 652

Gud', M.V. 1978: Alpha 1-antitrypsin content of blood serum in chronic lung diseases. Klinicheskaia Meditsina 56(12): 102-105

Mölleken, K.; Oeser, M. 1978: Alpha 1-antitrypsin deficiency. Zeitschrift für Arztliche Fortbildung 72(2): 69-71

Tolaymat, N.; Figueroa-Colon, R.; Mitros, F.A. 1989: Alpha 1-antitrypsin deficiency (Pi SZ) and biliary atresia. Journal of Pediatric Gastroenterology and Nutrition 9(2): 256-260

Doeglas, H.M.; Klasen, E.C.; Bleumink, E. 1985: Alpha 1-antitrypsin deficiency and Pi typing in patients with chronic urticaria. British Journal of Dermatology 112(4): 381-385

Fos, E.; Arcas, R.; Cabré, J.; Hierro, F.R.; Jiménez, R. 1986: Alpha 1-antitrypsin deficiency and atresia of the bile ducts. Anales Espanoles de Pediatria 25(6): 467-470

Stoller, J.K. 1989: Alpha 1-antitrypsin deficiency and augmentation therapy in emphysema. Cleveland Clinic Journal of Medicine 56(7): 683-689

Wieser, O.; Puganigg, K. 1976: Alpha 1-antitrypsin deficiency and chronic bronchitis. Wiener Medizinische Wochenschrift 126(28-31): 455-456

Dyan, A.; Bignon, J. 1977: Alpha 1-antitrypsin deficiency and chronic obstructive bronchopneumopathies. Revue Francaise de Transfusion et Immuno-Hematologie 20(1): 89-93

Garver, R.I.; Mornex, J.F.; Nukiwa, T.; Brantly, M.; Courtney, M.; LeCocq, J.P.; Crystal, R.G. 1986: Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes. New England Journal of Medicine 314(12): 762-766

Johansen, S.; Gulsvik, A. 1989: Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(22): 2142-2145

Blackwood, R.A.; Cerreta, J.M.; Mandl, I.; Turino, G.M. 1979: Alpha 1-antitrypsin deficiency and increased susceptibility to elastase-induced experimental emphysema in a rat model. American Review of Respiratory Disease 120(6): 1375-1379

McPhie, J.L.; Binnie, S.; Brunt, P.W. 1976: Alpha 1-antitrypsin deficiency and infantile liver disease. Archives of Disease in Childhood 51(8): 584-588

Sassaris, M.P.; Trinkl, W.; Meka, R.; Gonzales, P.; Torres, O.; Leach, R.; Hunter, F.M. 1985: Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. Southern Medical Journal 78(1): 52-57

Eriksson, S. 1987: Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. Acta Medica Scandinavica 221(5): 461-467

Birrer, P.; McElvaney, N.G.; Chang-Stroman, L.M.; Crystal, R.G. 1991: Alpha 1-antitrypsin deficiency and liver disease. Journal of Inherited Metabolic Disease 14(4): 512-525

Kristensen, E.; Nielsen, E.A. 1979: Alpha 1-antitrypsin deficiency and liver disease in children. Ugeskrift for Laeger 141(35): 2391-2392

Hussain, M.; Mieli-Vergani, G.; Mowat, A.P. 1991: Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment. Journal of Inherited Metabolic Disease 14(4): 497-511

Edmunds, S.E.; Wilkinson, M.L. 1991: Alpha 1-antitrypsin deficiency and pancreatitis in a juvenile. Australian and New Zealand Journal of Medicine 21(3): 345-347

Anonymous 1987: Alpha 1-antitrypsin deficiency and prenatal diagnosis. Lancet 1(8530): 421-422

Schmittenbecher, P.P.; Endres, W. 1990: Alpha 1-antitrypsin deficiency and prune-belly syndrome--first report of coincidence. Klinische Wochenschrift 68(6): 346

Jackson, C.G.; Stinson, J.M. 1979: Alpha 1-antitrypsin deficiency and status asthmaticus in a black teen-ager. Southern Medical Journal 72(9): 1222-1223

Gourley, M.F.; Gourley, G.R.; Gilbert, E.F.; Odell, G.B. 1989: Alpha 1-antitrypsin deficiency and the PiMS phenotype: case report and literature review. Journal of Pediatric Gastroenterology and Nutrition 8(1): 116-121

Klasen, E.C.; Biemond, I.; Laros, C.D. 1986: Alpha 1-antitrypsin deficiency and the flaccid lung syndrome. the heterozygote controversy. Clinical Genetics 29(3): 211-215

Hendrick, S.J.; Silverman, A.K.; Solomon, A.R.; Headington, J.T. 1988: Alpha 1-antitrypsin deficiency associated with panniculitis. Journal of the American Academy of Dermatology 18(4 Part 1): 684-692

Curiel, D.; Brantly, M.; Curiel, E.; Stier, L.; Crystal, R.G. 1989: Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin. Journal of Clinical Investigation 83(4): 1144-1152

Alagille, D. 1985: Alpha 1-antitrypsin deficiency in childhood. Revue Francaise de Transfusion et Immuno-Hematologie 28(6): 571-579

Szczeklik, A.; Stachura, J.; Szczudrawa, J.; Sowa, J.; Woźny, E.; Bogdal, J.; Pietoń, R. 1977: Alpha 1-antitrypsin deficiency in chronic liver disease. Polski Tygodnik Lekarski 32(27): 1033-1036

Buist, A.S. 1989: Alpha 1-antitrypsin deficiency in lung and liver disease. Hospital Practice 24(5): 51-59

Kishore, N.; Wahal, P.K.; Patney, N.L.; Tripathi, H.N. 1988: Alpha 1-antitrypsin deficiency in nephrotic syndrome. Journal of the Indian Medical Association 86(3): 61-62

Del Real Llorente, M.; Otero Rodríguez, J.A.; Bachiller Luque, R. 1991: Alpha 1-antitrypsin deficiency in primary care. Atencion Primaria 8(2): 165

Su, W.P.; Smith, K.C.; Pittelkow, M.R.; Winkelmann, R.K. 1987: Alpha 1-antitrypsin deficiency panniculitis: a histopathologic and immunopathologic study of four cases. American Journal of Dermatopathology 9(6): 483-490

Thatcher, B.S.; Winkelman, E.I.; Tuthill, R.J. 1985: Alpha 1-antitrypsin deficiency presenting as cryptogenic cirrhosis in adults over 50. Journal of Clinical Gastroenterology 7(5): 405-408

Fujita, A.; Katoh, K.; Shimizu, H.; Hasako, K. 1992: Alpha 1-antitrypsin deficiency with bronchiectasis in two sisters. Nihon Kyobu Shikkan Gakkai Zasshi 30(5): 952-958

De la Oliva Senovilla, P.; Díaz Fernández, M.C.; Hierro Llanillo, L.; Larrauri Martínez, J.; Jara Vega, P. 1989: Alpha 1-antitrypsin deficiency with histologic expression of metabolic disease of carbohydrates. Anales Espanoles de Pediatria 30(2): 137-139

Littleton, E.T.; Bevis, L.; Hansen, L.J.; Peakman, M.; Mowat, A.P.; Mieli-Vergani, G.; Vergani, D. 1991: Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease. Journal of Clinical Pathology 44(10): 855-858

Crystal, R.G. 1990: Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. Journal of Clinical Investigation 85(5): 1343-1352

Keim, H.J.; Farack, U.M.; Gabbert, H. 1979: Alpha 1-antitrypsin deficiency, liver cirrhosis and pulmonary emphysema. Leber Magen Darm 9(5): 272-276

Foreman, R.C. 1987: Alpha 1-antitrypsin deficiency--a defect in secretion. Bioscience Reports 7(4): 307-311

Buist, A.S. 1990: Alpha 1-antitrypsin deficiency--diagnosis, treatment, and control: identification of patients. Lung 168 Suppl: 543-551

Edmonds, B.K.; Hodge, J.A.; Rietschel, R.L. 1991: Alpha 1-antitrypsin deficiency-associated panniculitis: case report and review of the literature. Pediatric Dermatology 8(4): 296-299

Schneider, M.; Pott, G.; Gerlach, U. 1986: Alpha 1-antitrypsin deficiency: a review with special reference to the significance of heterozygous deficiency. Klinische Wochenschrift 64(5): 197-205

Myles, P.S.; Weeks, A.M. 1992: Alpha 1-antitrypsin deficiency: circulatory arrest following induction of anaesthesia. Anaesthesia and Intensive Care 20(3): 358-362

Eriksson, S. 1989: Alpha 1-antitrypsin deficiency: lessons learned from the bedside to the gene and back again. Historic perspectives. Chest 95(1): 181-189

Crystal, R.G. 1991: Alpha 1-antitrypsin deficiency: pathogenesis and treatment. Hospital Practice 26(2): 81

Cutz, E.; Cox, D.W. 1979: Alpha 1-antitrypsin deficiency: the spectrum of pathology and pathophysiology. Perspectives in Pediatric Pathology 5: 1-39

Strygler, B.; Nicar, M.J.; Santangelo, W.C.; Porter, J.L.; Fordtran, J.S. 1990: Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology 99(5): 1380-1387

Buraczynska, M.; Schött, D.; Hanzlik, A.J.; Höltmann, B.; Ulmer, W.T. 1987: Alpha 1-antitrypsin gene polymorphism related to respiratory system disease. Klinische Wochenschrift 65(12): 538-541

Nukiwa, T.; Seyama, K.; Takahashi, H.; Kira, S. 1992: Alpha 1-antitrypsin genes in patients with alpha 1AT deficiency in Japan: mutational analysis and allelic background. Nihon Kyobu Shikkan Gakkai Zasshi 30(8): 1420-1426

Brind, A.M.; Bassendine, M.F.; Bennett, M.K.; James, O.F. 1990: Alpha 1-antitrypsin granules in the liver--always important?. Quarterly Journal of Medicine 76(279): 699-709

Saari, K.M.; Kaarela, K.; Korpela, T.; Laippala, P.; Frants, R.R.; Eriksson, A.W. 1986: Alpha 1-antitrypsin in acute anterior uveitis and rheumatic diseases. Acta Ophthalmologica 64(5): 522-529

Guibaud, S.; Bonnet, M.; Thoulon, J.M.; Dumont, M. 1975: Alpha 1-antitrypsin in amniotic fluid. Obstetrics and Gynecology 45(1): 34-38

Pearl, G.S.; Mullins, R.E. 1985: Alpha 1-antitrypsin in cerebrospinal fluid of patients with neurologic diseases. Archives of Neurology 42(8): 775-777

Wang, S.X. 1990: Alpha 1-antitrypsin in clinical diagnosis of primary hepatic carcinoma--an appraisal of monoclonal antibody-rate nephelometry. Zhonghua Zhong Liu Za Zhi 12(1): 37-39

Dalmasso, F.; Pellegrino, S.; Trapani, C.; Bellero, V. 1976: Alpha 1-antitrypsin in the blood and pleural effusion fluid. Minerva Medica 67(49): 3207-3212

Kardash, B.E.; Geĭtman, I.I. 1978: Alpha 1-antitrypsin in the blood serums of oncological patients. Voprosy Onkologii 24(10): 80-82

Rujner, J.; Rosikiewicz, E.; Mikulska, B.; Pawłowska, J.; Socha, J. 1986: Alpha 1-antitrypsin in the serum of children with chronic liver diseases. Pediatria Polska 61(11): 698-701

Mason, D.Y.; Cramer, E.M.; Massé, J.M.; Crystal, R.; Bassot, J.M.; Breton-Gorius, J. 1991: Alpha 1-antitrypsin is present within the primary granules of human polymorphonuclear leukocytes. American Journal of Pathology 139(3): 623-628

Gulsvik, A.; Fagerhol, M.K. 1979: Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo. Scandinavian Journal of Respiratory Diseases 60(5): 267-274

Piłacik, B. 1987: Alpha 1-antitrypsin phenotypes and their role in medical diagnosis. Medycyna Pracy 38(5): 376-383

Piłacik, B.; Rujner, J.; Socha, J.; Madaliński, K.; Cianciara, J.; Mian, N. 1990: Alpha 1-antitrypsin phenotypes and their role in the development of early and late cirrhosis of the liver. Wiadomosci Lekarskie 43(12): 553-558

Theodoropoulos, G.; Fertakis, A.; Archimandritis, A.; Kapordelis, C.; Angelopoulos, B. 1976: Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma. Acta Hepato-Gastroenterologica 23(2): 114-117

Portenko, G.M. 1989: Alpha 1-antitrypsin phenotypes in healthy persons and patients with polypous rhinosinusitis. Vestnik Otorinolaringologii 3: 24-27

Deam, D.R.; Byron, K.A.; Ratnaike, S.; Campbell, D.G.; Mulhall, B.P.; Mackay, I.R. 1989: Alpha 1-antitrypsin phenotypes in homosexual men. Pathology 21(2): 91-92

Cohen, J.R.; Sarfati, I.; Ratner, L.; Tilson, D. 1990: Alpha 1-antitrypsin phenotypes in patients with abdominal aortic aneurysms. Journal of Surgical Research 49(4): 319-321

Hietala, J.; Rantala, H.; Hakala, M.; Koivisto, O. 1987: Alpha 1-antitrypsin phenotypes in rheumatoid arthritis. Arthritis and Rheumatism 30(8): 958-959

Petrukhin, I.S. 1987: Alpha 1-antitrypsin phenotypes of healthy persons and chronic bronchitis patients. Terapevticheskii Arkhiv 59(9): 112-115

Michalski, J.P.; McCombs, C.C.; Scopelitis, E.; Biundo, J.J.; Medsger, T.A. 1986: Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis and Rheumatism 29(5): 586-591

Nowak, S.; Czech, E.; Cicha, A. 1989: Alpha 1-antitrypsin polymorphism. Postepy Higieny i Medycyny Doswiadczalnej 43(2-4): 213-235

Sveger, T.; Mazodier, P. 1979: Alpha 1-antitrypsin screening of 18-year-old men. Thorax 34(3): 397-400

Jórdeczka, S.; Tesarczyk, K. 1976: Alpha 1-antitrypsin serum levels in patients with chronic non-specific respiratory diseases. Pneumonologia Polska 44(8-9): 899-905

El-Kassimi, F.A.; Warsy, A.S.; Uz-Zaman, A.; Pillai, D.K. 1989: Alpha 1-antitrypsin serum levels in widespread bronchiectasis. Respiratory Medicine 83(2): 119-121

Rudduck, C.; Franzén, G.; Lindström, L. 1985: Alpha 1-antitrypsin types in schizophrenia. Human Heredity 35(3): 193-195

Pittschieler, K.; Massi, G.; Menchicchi, F.; Chiarelli, C.; Marino, A. 1990: Alpha 1-antitrypsin typing test evaluated. Clinical Chemistry 36(1): 179-180

Luisetti, M.; Pozzi, E.; Diomede, L.; Donnini, M.; Piccioni, P.D.; Bolzoni, G.; Peona, V.; Salmona, M. 1990: Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. International Journal of Tissue Reactions 12(6): 363-368

Anonymous 1992: Alpha 1-antitrypsin, Z, and the liver. Lancet 340(8816): 402-403

Dumitraşcu, D.; Radu, D.; Stanciu, L.; Ioniţă, A.; Petcovici, M. 1989: Alpha 1-antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer. Revista de Medicina Interna Neurologe Psihiatrie Neurochirurgie Dermato-Venerologie. Medicina Interna 41(1): 57-61

Biagioni, S.; Stella, F.; Mannello, F.; Cerroni, L.; Stella, C.; Troccoli, R. 1985: Alpha 1-antitrypsin, transferrin, alkaline phosphatase, phosphohexoseisomerase and gamma-glutamyltransferase in breast cyst fluid. Tumori 71(2): 135-140

Gadek, J.E. 1987: Alpha 1-antitrypsin--an investigative odyssey from the benchtop to the bedside. Western Journal of Medicine 147(1): 79-80

Barker, A.F. 1992: Alpha 1-antitrypsin-deficiency-related emphysema. Journal of the American Board of Family Practice 5(5): 489-493

Abbott, C.M.; McMahon, C.J.; Kelsey, G.D.; Parkar, M.; Whitehouse, D.B.; Corney, G.; Povey, S.; Hopkinson, D.A.; Mieli-Vergani, G.; Mowat, A. 1987: Alpha 1-antitrypsin-related gene (ATR) for prenatal diagnosis. Lancet 1(8547): 1425-1426

Bhattacharyya, J.; Chaudhuri, L. 1990: Alpha 1-antitrypsin: a possible tool for diagnosis of cervical cancer. Biochemical Medicine and Metabolic Biology 43(3): 243-245

Kalsheker, N. 1989: Alpha 1-antitrypsin: structure, function and molecular biology of the gene. Bioscience Reports 9(2): 129-138

Berninger, R.W.; Teixeira, M.F. 1985: Alpha 1-antitrypsin: the effect of anticoagulants on the trypsin inhibitory capacity, concentration and phenotype. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 23(5): 277-281

Kincaid-Smith, P. 1989: Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein. Journal of Human Hypertension 3(Suppl 2): 75-83

Giannattasio, C.; Cattaneo, B.M.; Seravalle, G.; Carugo, S.; Mangoni, A.A.; Grassi, G.; Zanchetti, A.; Mancia, G. 1992: Alpha 1-blocking properties of carvedilol during acute and chronic administration. Journal of Cardiovascular Pharmacology 19(Suppl 1): S18-S22

Wollina, U.; Schulze, M.; Schaarschmidt, H.; Barta, U.; Pfeiffer, L.; Knopf, B.; Horn, A. 1985: Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?. Zeitschrift für Hautkrankheiten 60(6): 527-530

Rujner, J. 1988: Alpha 1-globulin analysis as a screening test for congenital alpha 1-antitrypsin deficiency. Polski Tygodnik Lekarski 43(25): 811-813

Veremeenko, K.N. 1985: Alpha 1-inhibitor of proteinases and its study in the clinic. Klinicheskaia Meditsina 63(12): 21-27

Vincent, C.; Revillard, J.P. 1987: Alpha 1-microglobulin (HC protein) and its IgA complex in human secretory fluids. Advances in Experimental Medicine and Biology 216b: 1231-1238

Vincent, C.; Kew, M.C.; Bouic, P.; Flacher, M.; Revillard, J.P. 1989: Alpha 1-microglobulin (HC protein) in human hepatocellular carcinoma. British Journal of Cancer 59(3): 415-416

Weber, M.H.; Verwiebe, R. 1992: Alpha 1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. European Journal of Clinical Chemistry and Clinical Biochemistry: Journal of the Forum of European Clinical Chemistry Societies 30(10): 683-691

Weber, M.H.; Scholz, P.; Stibbe, W.; Scheler, F. 1985: Alpha 1-microglobulin in the urine and serum in proteinuria and kidney insufficiency. Klinische Wochenschrift 63(15): 711-717

Lögdberg, L.; Akerström, B.; Shevach, E.M. 1986: Alpha 1-microglobulin is mitogenic for guinea pig lymphocytes. Scandinavian Journal of Immunology 24(5): 575-581

Babiker-Mohamed, H.; Olsson, M.L.; Boketoft, A.; Lögdberg, L.; Akerström, B. 1990: Alpha 1-microglobulin is mitogenic to human peripheral blood lymphocytes. Regulation by both enhancing and suppressive serum factors. Immunobiology 180(2-3): 221-234

Donaldson, M.D.; Chambers, R.E.; Woolridge, M.W.; Whicher, J.T. 1990: Alpha 1-microglobulin, beta 2-microglobulin and retinol binding protein in childhood febrile illness and renal disease. Pediatric Nephrology 4(4): 314-318

Bouic, P.; Kanitakis, J.; Schmitt, D.; Vincent, C.; Revillard, J.P.; Thivolet, J. 1985: Alpha 1-microglobulin: a new antigenic component of the epidermo-dermal junction in normal human skin. British Journal of Dermatology 112(1): 35-41

Menkes, D.B. 1991: Alpha 1-noradrenergic receptor binding in suicide victims. Archives of General Psychiatry 48(9): 859-860

Clark, A.S.; Nock, B.; Feder, H.H.; Roy, E.J. 1985: Alpha 1-noradrenergic receptor blockade decreases nuclear estrogen receptor binding in guinea pig hypothalamus and preoptic area. Brain Research 330(1): 197-199

Saha, N. 1990: Alpha 1-protease inhibitor (PI) subtypes in seven populations of east Asia. Annals of Human Biology 17(3): 229-234

Bleasby, A.J.; Knowles, J.C.; Cooper, E.H. 1986: Alpha 1-protease inhibitor in serous effusions: differences in lectin crossed immuno-affinoelectrophoresis precipitin profiles between benign and malignant disease. International Journal of Tissue Reactions 8(5): 393-400

Stone, P.J.; Lucey, E.C.; Virca, G.D.; Christensen, T.G.; Breuer, R.; Snider, G.L. 1990: Alpha 1-protease inhibitor moderates human neutrophil elastase-induced emphysema and secretory cell metaplasia in hamsters. European Respiratory Journal 3(6): 673-678

Kotova, T.S.; Basis, V.Iu.; Atovmian, O.I.; Andreeva, N.E.; Chernokhvostova, E.V. 1986: Alpha 1-protease inhibitor: characteristics of its biochemical and biological properties and its level in various diseases (review of the literature and personal observations). Terapevticheskii Arkhiv 58(4): 77-80

Stakishaĭtis, D.V.; Basis, V.I.; Kal'tianis, P.A. 1988: Alpha 1-proteinase inhibitor and alpha 2-macroglobulin in the blood serum of children with urinary infection. Pediatriia 10: 20-22

Trefz, G.; Schliesser, J.; Heck, B.; Schulz, V.; Ebert, W. 1992: Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema. Clinical Investigator 70(3-4): 269-276

Vereschagin, E.; Korolenko, T.; Arkhipov, S. 1992: Alpha 1-proteinase inhibitor and resistance to acute blood loss during injection of beta-1,3-carboxymethylglucan. Agents and Actions. Supplements 38: 198-202

Linstead, D.J.; Bradley, S. 1988: The purification and properties of two soluble reduced nicotinamide: acceptor oxidoreductases from Trichomonas vaginalis. Molecular and Biochemical Parasitology 27(2-3): 125-133

Barszcz, D.; Zarebska, Z.; Glińska-Ferenz, M.; Jabłońska, S.; Tigałonowa, M.; Gliński, W. 1988: Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare. Archives of Dermatological Research 280(4): 198-206

Banda, M.J.; Rice, A.G.; Griffin, G.L.; Senior, R.M. 1988: Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. Journal of Biological Chemistry 263(9): 4481-4484

Fingerle, J.; Sanders, K.H.; Fotev, Z. 1991: Alpha 1-receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury. Basic Research in Cardiology 86(Suppl 1): 75-81

Strasser, R.H.; Braun-Dullaeus, R.; Walendzik, H.; Marquetant, R. 1992: Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia. Mechanisms for sensitization of the adenylyl cyclase system. Circulation Research 70(6): 1304-1312

Takayanagi, I.; Moriya, M. 1991: Alpha 1A-adrenoceptors in rabbit bronchus. European Journal of Pharmacology 202(2): 281-283

Takayanagi, I.; Shiraishi, K.; Kokubu, N. 1992: Alpha 1B-adrenoceptor mechanisms in rabbit iris dilator. Japanese Journal of Pharmacology 59(3): 301-305

Abiodun, P.O.; Olomu, I.N. 1987: Alpha 2 HS-glycoprotein levels in children with protein-energy malnutrition and infections. Journal of Pediatric Gastroenterology and Nutrition 6(2): 271-275

Scacchi, R.; Lucarelli, P.; Corbo, R.M. 1989: Alpha 2 HS-glycoprotein phenotype and allele distribution in continental Italy and Sardinia. Human Heredity 39(1): 52-54

Nord, E.P.; Howard, M.J.; Hafezi, A.; Moradeshagi, P.; Vaystub, S.; Insel, P.A. 1987: Alpha 2 adrenergic agonists stimulate Na+-H+ antiport activity in the rabbit renal proximal tubule. Journal of Clinical Investigation 80(6): 1755-1762

Lagneaux, D.; Lecomte, J. 1990: Alpha 2 adrenergic control of ventilation in the rat. Archives Internationales de Physiologie et de Biochimie 98(6): 445-453

Shapiro, E.; Lepor, H. 1986: Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine. Journal of Urology 135(5): 1038-1042

Curtis, A.L.; Marwah, J. 1986: Alpha 2 adrenoceptors modulate the nociceptive jaw-opening reflex in rats. Experimental Neurology 91(3): 524-531

Pham, N.A.; Faulhaber, H.D.; Misselwitz, F.; Naumann, E.; Norden, C.; Martin, G.; Suessmilch, R. 1988: Alpha 2 adrenoceptors of blood platelets from hypertensive and normotensive rhesus monkeys. Folia Haematologica 115(4): 465-468

Doherty, T. 1989: Alpha 2 antagonists. Annals of Emergency Medicine 18(6): 710-711

Faltýnek, L.; Rozprýmová, L.; Fischerovä, E.; Krc, I.; Kudela 1978: Alpha 2 glycoprotein in neoplastic diseases. Vnitrni Lekarstvi 24(3): 242-248

Newland, A.C.; Jones, L.; Mir, N.; Slocombe, G.W. 1987: Alpha 2 interferon in chronic myeloid leukaemia following relapse post-allogeneic transplant. British Journal of Haematology 66(1): 141-143

Hershman, M.J.; Habib, N.A.; Apostolov, K.; Barker, W.; Wood, C.B. 1988: Alpha 2 interferon in the prevention of N-nitroso-methyl urea induced breast cancer in rats. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 14(3): 249-251

Donnelly, P.K.; Edwards, C.; Condie, R. 1990: Alpha 2 macroglobulin and the protease-inhibitory activity of colloid pancreatic preservation solutions. Transplantation Proceedings 22(2): 535-536

Banks, R.E.; Evans, S.W.; Alexander, D.; Van Leuven, F.; Whicher, J.T.; McMahon, M.J. 1991: Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut 32(4): 430-434

Hoffman, M.; Pizzo, S.V.; Weinberg, J.B. 1988: Alpha 2 macroglobulin-proteinase complexes stimulate prostaglandin E2 synthesis by peritoneal macrophages. Agents and Actions 25(3-4): 360-367

Deng, C.; Li, S.; Li, G.; Qiao, X.; He, C.; Guan, J. 1992: Alpha 2 megaloglobulin inhibits the activation of rabbit platelet by Chinese Agkistrodon acutus venom. Hua Xi Yi Ke da Xue Xue Bao 23(4): 416-419

Neuhaus, O.W. 1988: Alpha 2 mu-globulin: a model protein for studies of the renal reabsorption of low molecular weight proteins. Contributions to Nephrology 68: 32-36

Millan, M.J.; Colpaert, F.C. 1991: Alpha 2 receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in mice. Brain Research 539(2): 342-346

Rosina, F.; Saracco, G.; Lattore, V.; Quartarone, V.; Rizzetto, M.; Verme, G.; Trinchero, P.; Sansalvadore, F.; Smedile, A. 1987: Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. Progress in Clinical and Biological Research 234: 299-303

Yamashita, Y.; Imai, Y.; Osawa, T. 1989: Alpha 2,3-linked sialic acids are more abundant in CD45 antigens and leukosialins of abnormal T cells of lpr mice than in those of normal T cells. Journal of Biochemistry 106(6): 961-965

Dall'Olio, F.; Malagolini, N.; Di Stefano, G.; Ciambella, M.; Serafini-Cessi, F. 1991: Alpha 2,6 sialylation of N-acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growth. International Journal of Cancer 47(2): 291-297

Schultz, K.D.; Fritschka, E.; Kribben, A.; Rothschild, M.; Thiede, H.M.; Distler, A.; Philipp, T. 1989: Alpha 2- and beta 2-adrenoceptor downregulation in marathon runners. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 7(6): S48-S49

Richelsen, B.; Sørensen, N.S. 1987: Alpha 2- and beta-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism, Clinical and Experimental 36(11): 1031-1039

Kosugi, S.; Mori, T.; Iwamori, M.; Nagai, Y.; Imura, H. 1989: Alpha 2- and beta-adrenergic receptors and adenosine A1 receptor of FRTL-5 rat thyroid cells in relation to fucosyl GM1 ganglioside. Endocrinology 124(6): 2707-2710

Arnaud, P.; Miribel, L.; Emerson, D.L. 1988: Alpha 2-HS glycoprotein. Methods in Enzymology 163: 431-441

Eichner, J.E.; Friedrich, C.A.; Cauley, J.A.; Kamboh, M.I.; Gutai, J.P.; Kuller, L.H.; Ferrell, R.E. 1990: Alpha 2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women. Calcified Tissue International 47(6): 345-349

Yang, F.; Schwartz, Z.; Swain, L.D.; Lee, C.C.; Bowman, B.H.; Boyan, B.D. 1991: Alpha 2-HS-glycoprotein: expression in chondrocytes and augmentation of alkaline phosphatase and phospholipase A2 activity. Bone 12(1): 7-15

Devesa, J.; Arce, V.; Lois, N.; Tresguerres, J.A.; Lima, L. 1990: Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. Journal of Clinical Endocrinology and Metabolism 71(6): 1581-1588

Roquebert, J.; Grenié, B. 1986: Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats. Archives Internationales de Pharmacodynamie et de Therapie 284(1): 30-37

Flacke, J.W. 1992: Alpha 2-adrenergic agonists in cardiovascular anesthesia. Journal of Cardiothoracic and Vascular Anesthesia 6(3): 344-359